https://curecurrent.com/trials/a-clinical-study-to-assess-the-effect-of-vildagliptin-on-postprandial-lipid-parameters-in-patients-with-type-2-diabetes-23001https://curecurrent.com/trials/pharmacokinetic-study-of-laf237-and-its-metabolites-in-mild-renal-impaired-patients-23002https://curecurrent.com/trials/a-clinical-study-to-assess-the-efficacy-and-safety-of-vildagliptin-in-patients-with-type-2-diabetes-23003https://curecurrent.com/trials/effects-of-short-term-intensive-insulin-therapy-in-newly-diagnosed-type-2-diabetes-patients-23004https://curecurrent.com/trials/evaluation-of-the-performance-and-use-of-non-invasive-glucose-monitoring-device-23005https://curecurrent.com/trials/extension-study-of-the-long-term-safety-and-tolerability-of-octreotide-acetate-in-patients-with-moderately-severe-or-sev-23006https://curecurrent.com/trials/attachment-style-of-type-2-diabetics-and-cognitive-social-and-emotional-variables-as-explanatory-factors-of-adherence-to-23007https://curecurrent.com/trials/single-dose-study-with-a-new-insulin-glargine-formulation-and-lantus-in-japanese-patients-with-type-1-diabetes-mellitus-23008https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-inhaled-technosphere-insulin-in-patients-with-type-2-diabetes-23009https://curecurrent.com/trials/igf-i-induced-muscle-glucose-uptake-and-interstitial-igf-i-concentrations-23010https://curecurrent.com/trials/pharmaceutical-care-of-patients-with-impaired-mobility-in-a-model-region-of-decreasing-supply-of-medical-services-23011https://curecurrent.com/trials/18-week-randomized-double-blind-placebo-controlled-forced-titration-study-of-patients-with-type-2-diabetes-23012https://curecurrent.com/trials/use-of-beta-blockers-and-risk-of-new-onset-diabetes-23013https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-effects-of-nateglinide-vs-glibenclamide-on-renal-hemodynamics-and-albumin-excretion-23014https://curecurrent.com/trials/islet-allotransplantation-with-steroid-free-immunosuppression-23015https://curecurrent.com/trials/metabolic-effects-of-a-pre-meal-protein-drink-with-or-without-added-amino-acids-at-a-subsequent-composite-meal-23016https://curecurrent.com/trials/vitamin-d-receptor-polymorphisms-and-efficacy-of-vitamin-d-fortified-yogurt-drink-in-patients-with-type-2-diabetes-23017https://curecurrent.com/trials/small-dense-low-density-lipoprotein-in-patients-with-prediabetes-and-type-2-diabetes-23018https://curecurrent.com/trials/point-of-care-hba1c-as-a-screening-test-for-type-2-diabetes-in-first-nations-23019https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-blood-pressure-and-hba1c-levels-in-patients-with-t2d-23020https://curecurrent.com/trials/randomized-double-blind-study-to-assess-the-efficacy-and-safety-of-lipoic-acid-versus-bk-c-0701-in-subjects-with-diabeti-23021https://curecurrent.com/trials/closed-loop-control-of-glucose-levels-in-the-context-of-exercise-in-adults-with-type-1-diabetes-23022https://curecurrent.com/trials/dose-effect-relationship-of-low-dose-il-2-in-type-1-diabetes-23023https://curecurrent.com/trials/assessment-of-the-effect-of-tegaserod-2-mg-tid-and-6-mg-tid-on-dyspeptic-symptoms-in-diabetic-patients-with-symptoms-of-23024https://curecurrent.com/trials/accuracy-reliability-and-safety-of-glucomen-day-a-new-generation-microdialysis-continuous-glucose-monitor-23025https://curecurrent.com/trials/investigation-of-the-impact-of-different-application-volumes-of-insulin-aspart-in-subjects-with-type-1-diabetes-23026https://curecurrent.com/trials/the-effect-of-green-tea-or-cocoa-extracts-in-endothelial-dysfunction-in-patients-with-diabetes-mellitus-23027https://curecurrent.com/trials/the-adherence-index-the-indicator-of-effective-coping-with-the-requirements-of-the-disease-of-children-and-adolescents-w-23028https://curecurrent.com/trials/training-detraining-retraining-and-glycemic-control-in-patients-with-type-2-diabetes-23029https://curecurrent.com/trials/plant-stanols-and-type-1-diabetes-23030https://curecurrent.com/trials/dietary-modulation-of-gene-expression-and-metabolic-pathways-in-glucose-metabolism-23031https://curecurrent.com/trials/safety-and-efficacy-of-single-administration-of-oshadi-oral-insulin-in-type-i-diabetes-patients-23032https://curecurrent.com/trials/the-effect-of-nordic-recommended-diet-on-the-features-of-metabolic-syndrome-multicentre-study-23033https://curecurrent.com/trials/evaluating-the-effects-of-electroacupuncture-and-rosiglitazone-combined-therapy-23034https://curecurrent.com/trials/effect-of-a-vitamin-d-analogue-vs-placebo-on-p-nt-probnp-in-patients-with-type-1-dm-and-diabetic-nephropathy-23035https://curecurrent.com/trials/efficacy-and-safety-of-biphasic-insulin-aspart-30-for-the-treatment-of-type-2-diabetes-mellitus-23036https://curecurrent.com/trials/a-study-of-insulin-lispro-mix-in-type-2-diabetic-asian-patients-23037https://curecurrent.com/trials/effect-of-linagliptin-in-comparison-with-glimepiride-as-add-on-to-metformin-on-postprandial-beta-cell-function-postprand-23038https://curecurrent.com/trials/role-of-rosiglitazone-on-pre-diabetes-mellitus-and-coronary-artery-disease-23039https://curecurrent.com/trials/assessment-of-the-clinical-efficacy-and-acceptability-of-think-positive-t-in-diabetes-management-23040https://curecurrent.com/trials/extension-study-of-long-term-safety-and-tolerability-of-octreotide-acetate-in-patients-with-moderately-severe-or-severe-23041https://curecurrent.com/trials/effect-of-meal-frequency-on-insulin-resistance-in-subjects-with-type-2-diabetes-23042https://curecurrent.com/trials/a-first-time-in-human-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-ascending-doses-o-23043https://curecurrent.com/trials/phielix-et-al-hepatic-fat-content-and-adipokines-23044https://curecurrent.com/trials/adiponectin-and-asymmetric-dimethylarginine-adma-level-in-type-2-diabetes-patients-after-12-weeks-of-treatment-with-glim-23045https://curecurrent.com/trials/effect-of-incretin-related-drugs-on-dietary-intake-in-japanese-patients-with-type-2-diabetes-mellitus-23046https://curecurrent.com/trials/glufast-on-insulin-glargine-trial-in-type-2-dm-23047https://curecurrent.com/trials/mycophenolate-mofetil-carnitine-and-pde5-inhibitor-three-potential-treatments-for-resistant-proteinuria-slowing-diabetic-23048https://curecurrent.com/trials/effect-of-adding-vildagliptin-on-beta-cell-function-and-cardiovascular-risk-markers-in-patients-with-moderate-metabolic-23049https://curecurrent.com/trials/insulin-glargine-for-diabetes-metabolism-dm-type-ii-patients-under-enteral-nutrition-23050https://curecurrent.com/trials/diabetes-mellitus-care-decision-making-model-through-data-mining-23051https://curecurrent.com/trials/an-efficacy-and-safety-study-of-fixed-dose-rosiglitazone-glimepiride-to-treat-chinese-type-2-diabetes-patients-23052https://curecurrent.com/trials/clinical-usefulness-of-a-magnifier-for-insulin-pen-23053https://curecurrent.com/trials/stressors-coping-methods-and-social-support-in-diabetic-patients-23054https://curecurrent.com/trials/the-effect-of-anakinra-on-insulin-secretion-23055https://curecurrent.com/trials/potential-beneficial-effects-of-resveratrol-23056https://curecurrent.com/trials/cdrm-study-computer-assisted-diabetes-risk-management-for-secondary-and-tertiary-prevention-of-t2dm-complications-23057https://curecurrent.com/trials/self-titration-with-apidra-to-reach-target-study-start-23058https://curecurrent.com/trials/evaluation-of-negative-pressure-wound-therapy-in-the-treatment-of-dfus-incl-post-amputation-wounds-23059https://curecurrent.com/trials/exploring-buckwheat-s-glucose-lowering-potential-23060https://curecurrent.com/trials/52-week-add-on-to-metformin-comparison-of-saxagliptin-and-sulphonylurea-with-a-52-week-extension-period-23061https://curecurrent.com/trials/bone-marrow-autotransplantation-in-type-1-diabetes-23062https://curecurrent.com/trials/prevalence-of-peripheral-arterial-disease-in-subject-with-a-moderate-risk-of-cardiovascular-cv-disease-cvd-in-primary-pr-23063https://curecurrent.com/trials/intensive-insulin-therapy-in-non-diabetic-patients-with-acute-myocardial-infarction-and-hyperglycaemia-23064https://curecurrent.com/trials/long-term-of-10-years-results-of-a-prospective-longitudinal-study-23065https://curecurrent.com/trials/a-double-blind-randomized-active-comparator-metformin-controlled-clinical-trial-to-study-the-efficacy-and-safety-of-the-23066https://curecurrent.com/trials/a-dose-finding-study-of-topically-applied-i-020201-as-an-adjunct-to-good-standard-of-care-in-patients-with-chronic-diabe-23067https://curecurrent.com/trials/metabolic-effects-of-honey-in-type-1-diabetes-mellitus-23068https://curecurrent.com/trials/effect-of-dpp-iv-inhibitor-on-glycemic-control-and-autonomic-neuropathy-in-adult-patients-with-diabetes-mellitus-23069https://curecurrent.com/trials/prevalence-of-subclinical-atherosclerosis-and-its-associated-factors-in-hyperlipidemic-korean-adults-with-diabetes-23070https://curecurrent.com/trials/effect-of-palm-sugar-on-blood-glucose-concentrations-23071https://curecurrent.com/trials/2-5-and-10-phenylephrine-for-mydriasis-in-diabetic-patients-with-darkly-pigmented-irides-23072https://curecurrent.com/trials/sulfonylurea-effects-on-glucagon-regulation-during-hypoglycemia-in-type-1-dm-23073https://curecurrent.com/trials/comparing-the-efficacy-of-the-convatec-engenex-negative-pressure-wound-therapy-device-to-moist-wound-therapy-23074https://curecurrent.com/trials/evaluate-efficacy-and-safety-of-saxagliptin-in-combination-with-metformin-in-adult-patients-with-type-2-diabetes-23075https://curecurrent.com/trials/basal-insulin-for-type-2-diabetes-patients-treated-in-outpatient-clalit-clinics-23076https://curecurrent.com/trials/effects-of-n-acetylcysteine-on-diabetic-foot-oxygenation-23077https://curecurrent.com/trials/weight-loss-maintenance-wlm-23078https://curecurrent.com/trials/comparison-of-amlodipine-and-aliskiren-in-diabetic-hypertensive-patient-with-blood-pressure-not-controlled-by-losartan-23079https://curecurrent.com/trials/human-insulin-analogs-evaluation-of-inflammatory-mrna-expression-of-macrophages-and-endothelial-function-of-short-acting-23080https://curecurrent.com/trials/human-islet-transplantation-in-brittle-type-1-diabetes-mellitus-the-gragil-2-study-23081https://curecurrent.com/trials/effects-of-exercise-on-srage-levels-and-cardiometabolic-risk-factors-23082https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-dapagliflozin-as-monotherapy-in-subjects-with-type-2-diabetes-who-have-inadequate-g-23083https://curecurrent.com/trials/effect-of-mental-stress-on-glucose-control-in-patients-with-diabetes-mellitus-23084https://curecurrent.com/trials/efficacy-of-pioglitazone-on-macrovascular-outcome-in-patients-with-type-2-diabetes-23085https://curecurrent.com/trials/safety-comparison-of-pioglitazone-and-glyburide-in-type-2-diabetes-subjects-with-mild-to-moderate-congestive-heart-failu-23086https://curecurrent.com/trials/efficacy-of-pioglitazone-compared-to-glyburide-in-treating-subjects-with-type-2-diabetes-mellitus-and-mild-cardiac-disea-23087https://curecurrent.com/trials/safety-study-of-pioglitazone-compared-to-glyburide-on-liver-function-23088https://curecurrent.com/trials/efficacy-of-pioglitazone-on-microcirculation-in-type-2-diabetes-patients-treated-with-insulin-23089https://curecurrent.com/trials/observational-study-to-assess-glycosylated-hemoglobin-changes-after-6-months-of-treatment-with-pioglitazone-23090https://curecurrent.com/trials/safety-study-of-tak-128-in-subjects-with-diabetic-peripheral-neuropathy-23091https://curecurrent.com/trials/safety-and-efficacy-of-tak-559-in-combination-with-metformin-in-patients-with-type-2-diabetes-mellitus-23092https://curecurrent.com/trials/lixisenatide-for-restoration-of-insulin-release-in-subjects-with-diabetes-mellitus-type-2-23093https://curecurrent.com/trials/retrospective-study-hip-fractures-in-diabetic-patients-23094https://curecurrent.com/trials/mr-evaluation-of-renal-function-after-pancreas-transplantation-23095https://curecurrent.com/trials/telephone-intervention-in-patients-with-acute-coronary-syndrome-acs-and-diabetes-23096https://curecurrent.com/trials/stem-cell-educator-therapy-in-type-2-diabetes-23097https://curecurrent.com/trials/pump-study-mdi-lantus-lispro-vs-continuous-insulin-lispro-23098https://curecurrent.com/trials/effect-of-vasopressin-on-tissue-oxygen-saturation-in-cardiac-surgery-patients-during-cardiopulmonary-bypass-23099https://curecurrent.com/trials/polyphenols-and-insulin-resistance-23100https://curecurrent.com/trials/japanese-single-and-multiple-ascending-dose-safety-tolerability-pharmacokinetic-pk-pharmacodynamic-pd-study-of-azd7687-23101https://curecurrent.com/trials/safety-tolerability-and-pharmacodynamics-of-cyt013-il1bqb-in-patients-with-type-2-diabetes-23102https://curecurrent.com/trials/are-the-continuous-glucose-monitoring-systems-able-to-improve-long-term-glycaemic-control-in-type-1-diabetic-patients-23103https://curecurrent.com/trials/comparison-of-door-to-door-versus-community-gathering-to-provide-hiv-counseling-and-testing-services-in-rural-lesotho-23104https://curecurrent.com/trials/detecting-diabetes-sooner-with-a-risk-survey-for-the-family-doctor-comparing-internet-and-traditional-methods-of-communi-23105https://curecurrent.com/trials/multicenter-assessment-of-the-pda-fit-system-in-type-1-diabetic-patients-23106https://curecurrent.com/trials/immune-and-metabolic-effects-of-vitamin-d-supplementation-in-healthy-humans-23107https://curecurrent.com/trials/effect-of-treatment-with-metformin-in-type-2-diabetes-patients-on-alternative-genes-splicing-23108https://curecurrent.com/trials/improved-outcomes-associated-with-inositol-dietary-supplementation-in-women-with-gestational-diabetes-mellitus-23109https://curecurrent.com/trials/roux-en-y-versus-billroth-ii-reconstruction-after-subtotal-gastrectomy-in-gastric-cancer-comorbid-with-type-ii-diabetes-23110https://curecurrent.com/trials/the-verona-newly-diagnosed-type-2-diabetes-study-23111https://curecurrent.com/trials/clinical-decision-support-for-women-with-a-history-of-gestational-diabetes-23112https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-combination-with-thiazolidine-in-participants-with-type-2-diabetes-in-japan-23113https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-in-combination-with-glucosidase-inhibitor-in-participants-with-type-2-diabetes-in-23114https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-combination-with-metformin-in-participants-with-type-2-diabetes-in-japan-23115https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-in-participants-with-type-2-diabetes-in-japan-23116https://curecurrent.com/trials/study-for-the-artificial-pancreas-project-determination-of-a-tuning-strategy-of-metabolic-profiles-23117https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-used-in-combination-with-thiazolidine-in-participants-with-type-2-diabetes-in-japan-23118https://curecurrent.com/trials/affect-of-rt-cgms-as-part-of-clinical-care-in-type-1-diabetes-mellitus-patients-23119https://curecurrent.com/trials/long-term-safety-study-of-alogliptin-used-in-combination-with-glucosidase-inhibitor-in-participants-with-type-2-diabetes-23120https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-in-participants-with-type-2-diabetes-in-japan-23121https://curecurrent.com/trials/efficacy-and-safety-of-alogliptin-used-in-combination-with-sulfonylurea-in-participants-with-type-2-diabetes-in-japan-23122https://curecurrent.com/trials/safety-tolerability-and-activity-study-of-multiple-doses-of-isis-sglt2rx-in-healthy-volunteers-23123https://curecurrent.com/trials/safety-and-efficacy-study-of-alogliptin-on-glycemic-control-in-subjects-with-type-2-diabetes-23124https://curecurrent.com/trials/evaluation-of-the-tantalus-system-in-type-2-diabetic-subjects-23125https://curecurrent.com/trials/efficacy-and-safety-of-tak-559-combined-with-glyburide-in-treating-subjects-with-type-2-diabetes-mellitus-23126https://curecurrent.com/trials/a-study-of-three-pf-05190457-formulations-in-healthy-volunteers-23127https://curecurrent.com/trials/effect-of-dietary-protein-restriction-on-prognosis-in-patients-with-diabetic-nephropathy-23128https://curecurrent.com/trials/metformin-effects-on-oxidative-stress-parameters-in-newly-diagnosed-type-2-diabetes-patients-23129https://curecurrent.com/trials/diabetes-in-europe-prevention-using-lifestyle-physical-activity-and-nutritional-intervention-in-catalonia-23130https://curecurrent.com/trials/long-term-diabetes-improvement-after-cancer-gastrectomy-and-colectomy-23131https://curecurrent.com/trials/balance-system-study-in-type-2-diabetic-patients-23132https://curecurrent.com/trials/the-influence-of-adalimumab-on-cardiovascular-and-metabolic-risk-in-psoriasis-23133https://curecurrent.com/trials/efficacy-and-tolerability-of-saxagliptin-add-on-compared-to-uptitration-of-metformin-in-patients-with-type-2-diabetes-23134https://curecurrent.com/trials/efficacy-of-myo-inositol-in-preventing-gestational-diabetes-in-high-risk-pregnant-women-23135https://curecurrent.com/trials/risk-and-prevention-study-evaluation-of-the-efficacy-of-n-3-pufa-in-subjects-at-high-cardiovascular-risk-23136https://curecurrent.com/trials/the-effect-of-macronutrients-in-the-diet-on-digestive-and-cardiovascular-health-23137https://curecurrent.com/trials/comparison-of-efficacy-of-vitamin-d-and-vitamin-d-calcium-fortified-yogurt-drink-in-diabetic-patients-23138https://curecurrent.com/trials/the-titan-versus-everolimus-intracoronary-stent-xience-v-in-diabetic-patients-23139https://curecurrent.com/trials/study-of-metabolic-and-haemodynamic-effects-of-metformin-and-glimepiride-in-patients-with-type-2-diabetes-mellitus-23140https://curecurrent.com/trials/the-effect-of-fragmin-in-the-treatment-of-neuroischaemic-foot-ulcers-in-diabetic-patients-a6301086-23141https://curecurrent.com/trials/a-study-to-evaluate-p-glucose-safety-and-tolerability-after-oral-single-dosing-of-azd6370-in-type-2-diabetic-patients-23142https://curecurrent.com/trials/insulin-glargine-first-line-vs-metformin-in-type-2-diabetic-subjects-23143https://curecurrent.com/trials/risk-evaluation-of-cancers-in-chinese-diabetic-individuals-a-longitudinal-study-23144https://curecurrent.com/trials/the-effect-of-a-nutritional-supplement-in-individuals-with-type-2-diabetes-mellitus-a-pilot-study-23145https://curecurrent.com/trials/predictive-parameters-for-efficacy-of-sitagliptin-and-metformin-combination-23146https://curecurrent.com/trials/botulinum-toxin-a-for-treatment-of-catocholamine-induced-finger-necrosis-23147https://curecurrent.com/trials/performance-evaluation-of-blood-glucose-monitoring-systems-23148https://curecurrent.com/trials/exercise-intensity-glycemic-control-and-abdominal-fat-in-people-with-type-2-diabetes-a-pilot-study-23149https://curecurrent.com/trials/a-safety-pk-pd-study-of-slv337-in-patients-with-type-2-diabetes-23150https://curecurrent.com/trials/beta-cell-function-and-sitagliptin-trial-best-23151https://curecurrent.com/trials/insulin-detemir-action-in-cerebro-23152https://curecurrent.com/trials/performance-study-of-the-solo-2-0-insulin-pump-23153https://curecurrent.com/trials/establishing-cardiovascular-biomarkers-to-define-preferred-lantus-use-23154https://curecurrent.com/trials/comparing-the-expected-benefit-of-extra-corporeal-shockwave-therapy-eswt-treatment-to-standard-care-in-treating-diabetic-23155https://curecurrent.com/trials/the-effect-of-vitamin-d-supplementation-on-arterial-stiffness-in-diabetic-patients-23156https://curecurrent.com/trials/treatment-effects-of-atorvastatin-on-hemostasis-and-skin-microcirculation-in-patients-with-type-1-diabetes-23157https://curecurrent.com/trials/oral-bbr-012-in-the-treatment-of-diabetic-foot-ulcers-proof-of-concept-study-23158https://curecurrent.com/trials/effect-of-organic-naked-oat-with-whole-germ-on-type-2-diabetes-mellitus-23159https://curecurrent.com/trials/vitamin-d-inadequacy-on-postprandial-glucose-in-type-2-diabetes-mellitus-23160https://curecurrent.com/trials/bevacizumab-versus-ranibizumab-for-the-treatment-of-diabetic-macular-edema-23161https://curecurrent.com/trials/pre-mix-insulin-lispro-treatment-for-type-2-diabetes-patients-who-consume-a-light-breakfast-23162https://curecurrent.com/trials/exercise-and-pregnancy-randomized-clinical-trial-23163https://curecurrent.com/trials/macrophage-infiltration-in-human-adipose-tissue-23164https://curecurrent.com/trials/a-study-to-evaluate-the-postprandial-metabolic-response-after-use-of-glucerna-sr-in-obese-type-2-diabetes-23165https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-rosuvastatin-versus-simvastatin-in-type-2-diabetic-patients-with-dyslipidemia-23166https://curecurrent.com/trials/chinese-medicine-treatment-of-obesity-with-type-2-diabetes-dyslipidemia-23167https://curecurrent.com/trials/comparison-between-low-carbohydrate-diet-and-traditionally-recommended-diabetic-diet-in-the-treatment-of-diabetes-mellit-23168https://curecurrent.com/trials/genetic-association-of-diabetic-retinopathy-1-23169https://curecurrent.com/trials/a-study-of-ly2599506-oral-agent-medication-glucokinase-activator-1-in-type-2-diabetes-mellitus-23170https://curecurrent.com/trials/influence-of-acupuncture-to-ocular-microcirculation-in-patients-with-diabetes-mellitus-23171https://curecurrent.com/trials/effectiveness-of-nursing-care-plans-based-in-nursing-diagnoses-in-metabolic-control-of-type-2-diabetes-mellitus-23172https://curecurrent.com/trials/diabetes-resolution-and-hormone-changes-after-bpdll-and-lsg-23173https://curecurrent.com/trials/evaluation-of-posterior-capsule-opacification-in-eyes-with-diabetes-mellitus-23174https://curecurrent.com/trials/prevention-of-diabetes-mellitus-type-2-in-women-post-gestational-diabetes-mellitus-diagnosis-23175https://curecurrent.com/trials/medium-term-health-coaching-and-life-long-monitoring-in-cardiovascular-disease-in-norrbotten-23176https://curecurrent.com/trials/comparison-of-morning-and-evening-dosing-of-valsartan-and-lisinopril-in-patients-with-diabetes-23177https://curecurrent.com/trials/low-dose-carotene-supplementation-diminishes-oxidative-stress-in-type-2-diabetics-and-healthy-individuals-23178https://curecurrent.com/trials/managing-diabetes-during-pregnancy-in-the-wireless-age-23179https://curecurrent.com/trials/structured-diabetes-self-management-education-in-primary-care-and-metabolic-control-23180https://curecurrent.com/trials/effectiveness-of-the-self-monitoring-of-capillary-blood-glucose-at-home-23181https://curecurrent.com/trials/oxidative-stress-markers-evaluation-before-and-after-periodontal-treatment-of-diabetics-type-2-patients-23182https://curecurrent.com/trials/laparoscopic-adjustable-gastric-banding-with-truncal-vagotomy-23183https://curecurrent.com/trials/study-to-improve-quality-of-care-and-patient-health-in-the-field-of-cardiovascular-risk-factors-in-general-practice-23184https://curecurrent.com/trials/is-there-a-metabolic-effect-of-cinnamon-on-hba1c-blood-pressure-and-serum-lipids-in-type-2-diabetes-mellitus-23185https://curecurrent.com/trials/effectiveness-and-safety-of-two-approaches-to-the-management-of-type-2-diabetes-mellitus-in-australian-primary-care-23186https://curecurrent.com/trials/effect-of-vitamin-d-supplementation-on-fasting-glucose-and-interleukin-10-il-10-in-arab-women-with-impaired-fasting-gluc-23187https://curecurrent.com/trials/copeptin-for-risk-stratification-in-acute-stroke-patients-the-corisk-study-23188https://curecurrent.com/trials/the-effect-of-glycemic-control-on-malondialdehyde-glutathione-peroxidase-glutathione-and-paraoxonase-23189https://curecurrent.com/trials/evaluation-of-cissus-verticillata-l-infusion-in-controlling-type-2-diabetes-23190https://curecurrent.com/trials/the-effect-of-roux-en-y-gastric-bypass-on-mitochondrial-function-in-type-2-diabetes-23191https://curecurrent.com/trials/diabetogenicity-of-cyclosporine-and-tacrolimus-23192https://curecurrent.com/trials/valsartan-hydrochlorothiazide-combination-vs-amlodipine-in-patients-with-hypertension-diabetes-and-albuminuria-23193https://curecurrent.com/trials/antialbuminuric-effects-of-valsartan-and-lisinopril-23194https://curecurrent.com/trials/effect-of-valsartan-on-proteinuria-in-patients-with-hypertension-and-diabetes-mellitus-23195https://curecurrent.com/trials/effects-of-exercise-intervention-and-rehabilitation-exercise-intervention-in-patients-with-type-2-diabetes-23196https://curecurrent.com/trials/managing-insulin-pumps-for-exercise-study-1-23197https://curecurrent.com/trials/comparing-long-acting-insulins-during-exercise-in-type-1-diabetes-23198https://curecurrent.com/trials/hyperbaric-oxygen-therapy-as-adjunctive-treatment-of-chronic-diabetic-foot-ulcers-23199https://curecurrent.com/trials/vldl-triglyceride-kinetics-in-type-2-diabetes-23200https://curecurrent.com/trials/immune-profile-and-complication-risk-in-type-2-diabetes-23201https://curecurrent.com/trials/n-3-fatty-acid-infusion-and-type-2-diabetes-23202https://curecurrent.com/trials/single-anastomosis-duodeno-ileal-bypass-with-sleeve-gastrectomy-sadi-s-for-the-treatment-of-morbid-obesity-and-its-metab-23203https://curecurrent.com/trials/comparing-the-metabolic-control-of-once-to-twice-daily-insulin-detemir-injections-23204https://curecurrent.com/trials/effects-of-rosiglitazone-on-renal-hemodynamics-and-proteinuria-of-type-2-diabetic-patients-with-renal-insufficiency-due-23205https://curecurrent.com/trials/euglycemic-clamp-dose-response-study-comparing-a-new-insulin-glargine-formulation-with-lantus-23206https://curecurrent.com/trials/influence-of-pioglitazone-for-renal-transplant-function-in-diabetics-23207https://curecurrent.com/trials/peripheral-endothelial-function-and-coronary-status-in-asymptomatic-diabetic-patients-23208https://curecurrent.com/trials/effect-of-mulberry-leaf-extract-on-blood-glucose-23209https://curecurrent.com/trials/stress-relief-management-for-treatment-of-late-complications-in-type-2-diabetes-23210https://curecurrent.com/trials/aspirin-statins-or-both-for-the-reduction-of-thrombin-generation-in-diabetic-people-23211https://curecurrent.com/trials/self-monitoring-of-blood-glucose-in-insulin-treated-patients-with-type-2-diabetes-23212https://curecurrent.com/trials/glycemic-and-blood-pressure-control-in-type-2-diabetes-in-a-primary-care-unit-a-staged-management-strategy-23213https://curecurrent.com/trials/cabergoline-effect-on-blood-sugar-in-type-2-diabetics-23214https://curecurrent.com/trials/low-grade-inflammation-in-type-1-diabetes-children-23215https://curecurrent.com/trials/educative-intervention-to-improve-type-2-diabetes-mellitus-control-in-corrientes-23216https://curecurrent.com/trials/effects-of-food-advanced-glycation-endproducts-on-vascular-function-in-diabetes-23217https://curecurrent.com/trials/integrating-insulin-delivery-and-glucose-sensing-in-subcutaneous-tissue-for-the-treatment-of-type-1-diabetic-patients-23218https://curecurrent.com/trials/pathology-of-skin-nerve-and-vasculature-in-the-amputated-limb-of-diabetes-23219https://curecurrent.com/trials/drug-drug-interaction-study-of-dapagliflozin-with-voglibose-in-japanese-type-2-diabetes-mellitus-patients-23220https://curecurrent.com/trials/organization-program-of-diabetes-insulin-management-23221https://curecurrent.com/trials/resistant-hypertension-in-patients-with-type-ii-diabetes-mellitus-23222https://curecurrent.com/trials/evaluation-of-the-effect-of-vivostat-platelet-rich-fibrin-prf-in-the-treatment-of-diabetic-foot-ulcers-23223https://curecurrent.com/trials/a-phase-iii-study-to-investigate-the-impact-of-diamyd-in-patients-newly-diagnosed-with-type-1-diabetes-eu-23224https://curecurrent.com/trials/the-role-of-endogenous-glucagon-like-peptide-1-glp-1-in-type-2-diabetes-mellitus-t2dm-23225https://curecurrent.com/trials/caloric-restriction-and-insulin-secretion-23226https://curecurrent.com/trials/assessment-of-an-alternative-model-of-follow-up-of-children-and-adolescents-with-type-1-diabetes-23227https://curecurrent.com/trials/effect-of-sitagliptin-on-incretin-effect-in-patients-with-type-2-diabetes-mellitus-23228https://curecurrent.com/trials/vinegar-co-ingestion-in-type-2-diabetes-23229https://curecurrent.com/trials/evaluation-of-interests-of-fit-therapy-on-diabetics-children-insulin-dependent-23230https://curecurrent.com/trials/nerve-conduction-velocity-in-diabetic-children-23231https://curecurrent.com/trials/effect-of-self-monitoring-of-blood-glucose-in-patients-with-type-2-diabetes-mellitus-not-using-insulin-23232https://curecurrent.com/trials/evaluate-saxagliptin-in-adult-indian-patients-with-type-2-diabetes-inadequate-glycemic-control-23233https://curecurrent.com/trials/biological-efficacy-of-clopidogrel-after-implantation-of-drug-eluting-stents-space-23234https://curecurrent.com/trials/effect-of-intravitreal-bevacizumab-on-focal-edema-with-hard-exudates-secondary-to-diabetic-retinopathy-23235https://curecurrent.com/trials/acute-changes-in-intraocular-cytokines-after-intravitreal-bevacizumab-23236https://curecurrent.com/trials/study-of-24-hour-blood-pressure-and-the-association-to-complications-to-type-1-diabetes-23237https://curecurrent.com/trials/evaluate-efficacy-and-safety-of-saxagliptin-in-adult-patients-with-type-2-diabetes-inadequate-glycemic-control-23238https://curecurrent.com/trials/molecular-mediators-of-nerve-injury-signaling-23239https://curecurrent.com/trials/retinal-function-in-diabetic-patients-without-retinopathy-23240https://curecurrent.com/trials/simultaneous-islet-kidney-transplantation-in-patients-of-type-1-diabetes-with-end-stage-renal-disease-23241https://curecurrent.com/trials/effect-of-internet-therapeutic-intervention-on-a1c-levels-in-type-2-diabetes-mellitus-dm-on-monotherapy-23242https://curecurrent.com/trials/using-glucose-sensors-to-prevent-hypoglycemia-23243https://curecurrent.com/trials/hypoglycemia-physician-and-patient-perspectives-23244https://curecurrent.com/trials/the-cardiopathic-features-and-analysis-of-risk-factors-in-the-elderly-diabetic-23245https://curecurrent.com/trials/trial-comparing-different-medical-devices-for-infragenual-dilatation-23246https://curecurrent.com/trials/low-protein-diet-supplemented-with-ketoanalogs-on-reducing-proteinuria-and-maintaining-nutritional-status-in-type-2-diab-23247https://curecurrent.com/trials/endothelial-disfunction-treatment-with-glimepiride-metformin-combination-glimetal-in-type-2-diabetes-patients-23248https://curecurrent.com/trials/pharmacodynamics-of-mitiglinide-sitagliptin-compared-to-mitiglinide-and-sitagliptin-23249https://curecurrent.com/trials/a-multi-site-individually-randomized-controlled-translation-trial-of-integrated-and-comprehensive-care-strategies-to-red-23250https://curecurrent.com/trials/effect-of-olive-leaves-as-hypoglycemic-agents-in-diabetic-subjects-23251https://curecurrent.com/trials/the-swiss-glucose-variability-study-23252https://curecurrent.com/trials/comparative-study-of-hoe490-o-glimepiride-and-metformin-compared-with-placebo-on-top-of-glimepiride-23253https://curecurrent.com/trials/a-diabetes-study-to-treat-a-population-previously-not-at-target-23254https://curecurrent.com/trials/effects-on-nf-b-activity-high-dose-simvastatin-versus-combination-therapy-with-ezetimibe-23255https://curecurrent.com/trials/the-effect-of-leucine-on-body-composition-and-muscle-characteristics-in-elderly-type-2-diabetes-patients-23256https://curecurrent.com/trials/14-c-adme-absorption-disposition-metabolism-and-excretion-study-in-man-23257https://curecurrent.com/trials/effects-of-different-types-of-exercise-in-type-2-diabetes-23258https://curecurrent.com/trials/effect-of-coffee-consumption-on-the-glycemic-index-of-khalas-dates-tested-in-healthy-and-diabetic-subjects-23259https://curecurrent.com/trials/systemic-effects-of-epidural-methylprednisolone-injection-on-glucose-tolerance-in-diabetic-patients-23260https://curecurrent.com/trials/outcomes-of-non-infected-diabetic-foot-ulcers-with-without-antibiotics-23261https://curecurrent.com/trials/drug-drug-interaction-study-ckd-501-amlodipine-23262https://curecurrent.com/trials/multifactorial-intervention-in-type-2-diabetes-italy-23263https://curecurrent.com/trials/effectiveness-of-oral-insulin-in-unstable-type-1-diabetes-patients-23264https://curecurrent.com/trials/pharmacology-of-insulin-injected-with-jet-injection-23265https://curecurrent.com/trials/comparison-between-patients-with-or-without-diabetes-recovery-after-bariatric-surgery-23266https://curecurrent.com/trials/the-effect-of-vitamin-k-supplementation-on-glucose-metabolism-23267https://curecurrent.com/trials/maintenance-intravenous-fluids-in-children-23268https://curecurrent.com/trials/peanuts-second-meal-glycemic-response-23269https://curecurrent.com/trials/safety-and-efficacy-study-of-umbilical-cord-placenta-derived-mesenchymal-stem-cells-to-treat-type-2-diabetes-23270https://curecurrent.com/trials/lann-study-lantus-amaryl-novorapid-novomix-study-23271https://curecurrent.com/trials/target-site-pharmacokinetics-of-ertapenem-after-multiple-doses-in-diabetes-patients-with-soft-tissue-infection-23272https://curecurrent.com/trials/a-pilot-trial-of-the-endobarrier-flow-restrictor-for-glycemic-improvement-in-type-2-diabetics-23273https://curecurrent.com/trials/diabetes-exercise-and-lifestyle-trial-23274https://curecurrent.com/trials/tele-diab-electronic-diary-for-patients-with-type-2-diabetes-mellitus-23275https://curecurrent.com/trials/glycemic-and-satiety-response-to-fiber-and-glycemic-index-of-meals-in-diabetes-23276https://curecurrent.com/trials/imaging-of-islet-transplantation-with-pet-and-mrt-23277https://curecurrent.com/trials/aerobic-training-aerobic-resistance-training-and-glucose-profile-cgms-in-type-2-diabetes-23278https://curecurrent.com/trials/panretinal-photocoagulation-prp-plus-ranibizumab-for-proliferative-diabetic-retinopathy-23279https://curecurrent.com/trials/effect-of-enalapril-and-losartan-association-therapy-on-proteinuria-and-inflammatory-biomarkers-in-diabetic-nephropathy-23280https://curecurrent.com/trials/blood-glucose-self-monitoring-and-hba1c-effects-on-glucose-control-23281https://curecurrent.com/trials/skin-autofluorescence-af-decision-tree-in-detecting-impaired-glucose-tolerance-igt-or-diabetes-mellitus-dm-23282https://curecurrent.com/trials/probiotics-as-a-novel-approach-to-modulate-gut-hormone-secretion-and-risk-factors-of-type-2-diabetes-and-complications-23283https://curecurrent.com/trials/the-healing-effect-of-a-two-herb-recipe-on-foot-ulcer-in-chinese-patients-with-type-2-diabetes-23284https://curecurrent.com/trials/cognitive-behavioral-therapy-for-painful-diabetic-neuropathy-23285https://curecurrent.com/trials/safety-and-efficacy-of-arterial-delivery-of-autologous-bone-marrow-cells-in-the-treatment-of-insulin-dependent-diabetes-23286https://curecurrent.com/trials/lifestyle-intervention-in-patients-with-new-onset-type-2-diabetes-23287https://curecurrent.com/trials/prevalence-of-glucose-intolerance-and-risk-factors-in-ethiopian-immigrants-in-israel-follow-up-study-23288https://curecurrent.com/trials/study-of-how-single-rising-doses-of-sar161271-are-absorbed-and-act-in-patients-with-type-1-diabetes-mellitus-t1dm-23289https://curecurrent.com/trials/duloxetine-versus-placebo-in-the-treatment-of-patients-with-diabetic-peripheral-neuropathic-pain-in-china-23290https://curecurrent.com/trials/a-study-of-intra-dermal-injection-of-botulinum-toxin-type-a-for-the-diabetic-neuropathic-foot-pain-23291https://curecurrent.com/trials/a1c-discordance-in-diabetes-patients-23292https://curecurrent.com/trials/use-of-a-telehomecare-program-for-young-patients-with-new-onset-type-1-diabetes-23293https://curecurrent.com/trials/effect-of-fiber-supplementation-in-children-with-type-1-diabetes-23294https://curecurrent.com/trials/genetic-assessment-of-the-patients-with-metabolic-syndrome-23295https://curecurrent.com/trials/intravitreal-adalimumab-in-refractory-diabetic-retinopathy-choroidal-neovascularization-or-uveitis-a-pilot-study-23296https://curecurrent.com/trials/necessity-for-lipid-lowering-therapy-in-type-2-diabetes-patients-23297https://curecurrent.com/trials/managing-insulin-pumps-for-exercise-study-2-23298https://curecurrent.com/trials/glycemic-response-to-road-cycling-in-type-1-diabetes-23299https://curecurrent.com/trials/impact-of-diabetes-and-glucose-control-during-rehabilitation-after-stroke-23300https://curecurrent.com/trials/hba1c-and-diagnosis-of-type-2-diabetes-23301https://curecurrent.com/trials/elevated-triglyceride-levels-and-later-type-2-diabetes-23302https://curecurrent.com/trials/herbal-periodontal-patch-thpp-for-gingival-inflammation-in-diabetics-23303https://curecurrent.com/trials/pioglitazone-and-metformin-in-diabetic-children-23304https://curecurrent.com/trials/prepare-prediabetes-research-and-education-promoting-activity-responsible-eating-23305https://curecurrent.com/trials/cirrhosis-diabetes-23306https://curecurrent.com/trials/effects-of-aspirin-treatment-on-fibrin-network-formation-in-patients-with-type-1-diabetes-23307https://curecurrent.com/trials/efficacy-of-diazoxide-in-type-1-diabetes-23308https://curecurrent.com/trials/metformin-inflammation-in-pre-diabetic-children-23309https://curecurrent.com/trials/study-with-gft505-80mg-versus-placebo-in-patients-with-type-2-diabetes-mellitus-23310https://curecurrent.com/trials/determinants-of-insulin-induced-weight-gain-in-type-2-diabetes-mellitus-23311https://curecurrent.com/trials/efficacy-and-safety-of-pioglitazone-in-treating-subjects-with-vascular-complications-associated-with-type-2-diabetes-mel-23312https://curecurrent.com/trials/pyridostigmine-and-its-effects-on-autonomic-modulation-in-diabetic-patients-23313https://curecurrent.com/trials/ykl-40-and-complications-in-type-2-diabetes-23314https://curecurrent.com/trials/glucose-optimisation-with-angiotensin-ii-antagonist-losartan-goaal-23315https://curecurrent.com/trials/the-effect-of-gastric-bypass-surgery-on-the-glucose-metabolism-seen-in-patients-with-type-2-diabetes-23316https://curecurrent.com/trials/single-dose-escalation-study-of-pf-05190457-in-healthy-volunteers-23317https://curecurrent.com/trials/the-effectiveness-of-resistance-exercise-for-glycemic-control-in-type-2-diabetes-mellitus-patients-23318https://curecurrent.com/trials/educational-intervention-and-social-support-in-diabetes-mellitus-23319https://curecurrent.com/trials/effect-of-pioglitazone-on-testosterone-in-eugonadal-men-with-type-2-diabetes-mellitus-a-pilot-study-23320https://curecurrent.com/trials/the-effect-of-the-glp-1-analogue-exenatide-on-type-2-diabetes-in-cns-and-heart-during-hyperglycemia-assessed-by-pet-23321https://curecurrent.com/trials/bioavailability-of-technosphere-insulin-versus-subcutaneous-regular-human-insulin-in-type-2-diabetes-23322https://curecurrent.com/trials/drug-drug-interaction-study-ckd-501-ketoconazole-23323https://curecurrent.com/trials/effect-of-internet-therapeutic-intervention-on-a1c-levels-in-type-2-diabetes-mellitus-dm-on-combination-oral-therapy-23324https://curecurrent.com/trials/information-technology-methodology-for-patient-motivation-in-diabetes-management-23325https://curecurrent.com/trials/effect-of-doxium-on-high-sensitivity-crp-and-endothelin-1-serum-levels-in-patients-with-diabetic-retinopathy-23326https://curecurrent.com/trials/a-pharmacodynamic-study-of-slm0807-hkb0701-and-cj30001-in-healthy-subject-23327https://curecurrent.com/trials/effect-of-sitagliptin-on-postprandial-lipoprotein-metabolism-23328https://curecurrent.com/trials/constructed-intervention-by-home-and-school-diabetes-nurse-visits-on-diabetic-control-of-children-with-type-i-diabetes-23329https://curecurrent.com/trials/assessing-the-treatment-effect-in-metabolic-syndrome-without-perceptible-diabetes-attempt-23330https://curecurrent.com/trials/pinguin-postpartum-intervention-in-women-with-gestational-diabetes-using-insulin-23331https://curecurrent.com/trials/effects-of-different-types-of-exercise-interventions-in-patients-with-type-2-diabetes-23332https://curecurrent.com/trials/neurological-complications-at-stroke-patients-with-diabetes-mellitus-23333https://curecurrent.com/trials/the-effect-of-a-low-glycemic-index-diet-on-blood-sugar-control-in-women-with-gestational-hyperglycemia-23334https://curecurrent.com/trials/unknown-glucose-metabolism-disorders-in-patients-with-coronary-artery-disease-23335https://curecurrent.com/trials/plantar-faciitis-and-diabetes-mellitus-23336https://curecurrent.com/trials/fibre-and-appetite-regulation-trial-fart-23337https://curecurrent.com/trials/validation-study-of-coronary-ct-angiography-as-a-screening-tool-in-asymptomatic-diabetes-23338https://curecurrent.com/trials/addm-study-amtrel-and-co-diovan-in-type-2-diabetes-mellitus-hypertension-patients-with-microalbuminuria-23339https://curecurrent.com/trials/cotransplantation-of-islet-and-mesenchymal-stem-cell-in-type-1-diabetic-patients-23340https://curecurrent.com/trials/a-comparison-of-indapamide-sr-1-5-mg-with-hctz-25-mg-in-combination-with-an-ace-inhibitor-in-patients-with-mild-to-moder-23341https://curecurrent.com/trials/effect-of-conjugated-linoleic-acid-alone-and-in-conjunction-with-vitamin-e-in-patients-with-type-2-diabetes-mellitus-23342https://curecurrent.com/trials/nationwide-assessment-of-cardiovascular-risk-factors-in-chinese-patients-with-type-2-diabetes-23343https://curecurrent.com/trials/plasma-adiponectin-concentration-activity-and-isoforms-in-newly-diagnosed-and-untreated-type-2-diabetes-mellitus-23344https://curecurrent.com/trials/safety-of-diamyd-in-patients-with-lada-latent-autoimmune-diabetes-in-adult-23345https://curecurrent.com/trials/treatment-of-wounds-utilizing-light-23346https://curecurrent.com/trials/a-multiple-ascending-dose-study-in-type-2-diabetes-mellitus-patients-23347https://curecurrent.com/trials/a-pharmacokinetic-study-of-cj30001-and-hkb0701-slm0807-in-healthy-subject-23348https://curecurrent.com/trials/a-study-comparing-the-effectiveness-and-safety-of-tramadol-hcl-acetaminophen-versus-placebo-for-the-treatment-of-painful-23349https://curecurrent.com/trials/acetylcarnitine-and-insulin-sensitivity-23350https://curecurrent.com/trials/user-satisfaction-using-the-adi-insulin-pump-23351https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-dehypotin-in-the-patients-with-type-2-diabetes-mellitus-or-cardiovascular-disease-23352https://curecurrent.com/trials/the-effect-of-hyperglycemia-on-lv-function-and-exercise-capacity-in-diabetics-with-and-without-heart-failure-23353https://curecurrent.com/trials/diabetes-multicenter-observational-study-diamond-1-23354https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-topiramate-in-the-treatment-fo-obese-type-2-diabetic-patients-treated-with-metform-23355https://curecurrent.com/trials/monochromatic-phototherapy-on-diabetic-foot-ulcers-23356https://curecurrent.com/trials/a-study-on-efficacy-and-safety-of-topiramate-oros-controlled-release-in-obese-type-2-diabetic-subjects-managed-with-diet-23357https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-topiramate-in-the-treatment-of-obese-type-2-diabetes-patients-on-a-controlled-diet-23358https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-topiramate-in-obese-type-2-diabetic-patients-inadequately-controlled-on-sulfonylur-23359https://curecurrent.com/trials/insulin-glargine-during-and-after-the-period-of-fasting-in-ramadan-23360https://curecurrent.com/trials/evaluation-of-the-safety-follow-up-of-becaplermin-or-placebo-gel-following-treatment-of-chronic-full-thickness-diabetic-23361https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-topiramate-on-clinical-and-electrophysiological-parameters-in-subjects-with-diabetic-p-23362https://curecurrent.com/trials/insulin-glargine-in-type-1-diabetes-mellitus-23363https://curecurrent.com/trials/a-study-on-efficacy-and-safety-of-topiramate-in-treatment-of-obese-subjects-with-dyslipidemia-23364https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-topiramate-on-insulin-sensitivity-in-overweight-or-obese-patients-with-type-2-23365https://curecurrent.com/trials/a-study-of-safety-and-efficacy-of-topiramate-in-male-patients-with-abdominal-obesity-23366https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-long-term-treatment-and-re-treatment-of-lower-extremity-diabetic-ulcers-with-regra-23367https://curecurrent.com/trials/effect-of-the-chromium-nicotinate-on-type-2-diabetes-23368https://curecurrent.com/trials/a-study-of-pf-03882845-absorption-in-healthy-volunteers-given-orally-as-tablet-versus-suspension-formulations-and-effect-23369https://curecurrent.com/trials/feasibility-study-of-the-solo-insulin-pump-23370https://curecurrent.com/trials/primary-prevention-of-cardiovascular-disease-cvd-in-pre-diabetic-pre-hypertensive-subjects-23371https://curecurrent.com/trials/blood-pressure-and-glucose-lowering-diet-for-taiwanese-23372https://curecurrent.com/trials/repeated-dosing-study-with-a-new-insulin-glargine-formulation-and-lantus-in-patients-with-type-1-diabetes-mellitus-23373https://curecurrent.com/trials/primary-prevention-of-major-adverse-cardiac-events-mace-with-standard-and-intensive-statin-treatment-in-patients-with-di-23374https://curecurrent.com/trials/exercise-intensity-and-type-2-diabetics-23375https://curecurrent.com/trials/effect-of-bosentan-on-endothelial-function-in-patients-with-type-2-diabetes-23376https://curecurrent.com/trials/metabolic-and-endocrine-status-in-women-with-prior-preterm-birth-23377https://curecurrent.com/trials/a-study-of-the-effects-of-risperidone-and-olanzapine-on-blood-glucose-sugar-in-patients-with-schizophrenia-or-schizoaffe-23378https://curecurrent.com/trials/the-effect-of-metformin-on-the-correlation-between-hyperinsulinemia-and-hypertension-23379https://curecurrent.com/trials/the-flavo-trial-dietary-flavonoids-and-cardiovascular-disease-risk-reduction-in-postmenopausal-women-with-type-2-diabete-23380https://curecurrent.com/trials/a-comparison-study-of-basal-bolus-therapies-together-with-lispro-insulin-in-type-2-diabetes-patients-23381https://curecurrent.com/trials/metabolic-and-vascular-effects-of-statins-in-untreated-dyslipidemic-diabetic-patients-23382https://curecurrent.com/trials/gastric-bypass-versus-best-medical-treatment-on-progression-of-carotid-intima-media-thickness-in-type-2-diabetes-mellitu-23383https://curecurrent.com/trials/bacteriological-study-of-diabetic-foot-and-antibiotic-sensitivity-pattern-in-eastern-india-23384https://curecurrent.com/trials/the-effect-of-alcohol-on-abca1-expression-and-lipid-metabolism-23385https://curecurrent.com/trials/physical-activity-advice-in-diabetics-at-annual-review-23386https://curecurrent.com/trials/improving-metabolism-with-hdl-cholesterol-23387https://curecurrent.com/trials/orient-olmesartan-reducing-incidence-of-end-stage-renal-disease-in-diabetic-nephropathy-trial-23388https://curecurrent.com/trials/compare-the-effect-of-dpp-iv-inhibitor-or-tzd-on-glycemic-variability-and-oxidative-stress-in-patient-with-2-diabetes-23389https://curecurrent.com/trials/effectiveness-and-tolerability-of-tarka-in-the-treatment-of-hypertensive-patients-with-high-risk-of-developing-diabetes-23390https://curecurrent.com/trials/the-effect-of-natural-food-flavourings-on-gastrointestinal-and-cardiovascular-physiological-responses-23391https://curecurrent.com/trials/effects-of-3-months-of-supervised-exercise-training-23392https://curecurrent.com/trials/comparing-liquid-versus-solid-forms-of-sugars-and-whey-protein-23393https://curecurrent.com/trials/effects-of-intact-and-hydrolyzed-pea-protein-on-food-intake-glycemic-response-and-subjective-appetite-23394https://curecurrent.com/trials/effect-of-10mg-domperidone-on-gastric-emptying-of-a-high-fat-meal-and-appetite-sensations-in-healthy-adults-23395https://curecurrent.com/trials/diamel-in-the-treatment-of-type-2-diabetic-patients-receiving-insulin-therapy-23396https://curecurrent.com/trials/the-effects-of-short-time-high-intensity-interval-training-on-tissue-glucose-and-fat-metabolism-in-healthy-subjects-and-23397https://curecurrent.com/trials/copenhagen-obesity-risk-assessment-study-23398https://curecurrent.com/trials/sleep-impairment-and-coping-style-in-diabetes-23399https://curecurrent.com/trials/a-comparison-of-pharmacodynamics-and-pharmacokinetics-of-insulin-aspart-biasp70-biasp50-and-fast-acting-human-insulin-23400https://curecurrent.com/trials/effects-of-milk-derived-from-mountain-pasture-grazing-cows-on-risk-markers-of-the-metabolic-syndrome-compared-to-convent-23401https://curecurrent.com/trials/subclassification-of-the-syndrome-of-inappropriate-adh-secretion-23402https://curecurrent.com/trials/treatment-with-sitagliptin-for-reactive-hypoglycemia-secondary-to-dysinsulinism-23403https://curecurrent.com/trials/study-on-the-prognosis-and-effect-of-anti-diabetic-drugs-on-type-2-diabetes-mellitus-with-coronary-artery-disease-23404https://curecurrent.com/trials/the-safety-preliminary-pharmacodynamics-and-pharmacokinetics-study-of-rexenatide-4-in-chinese-type-2-diabetes-mellitus-23405https://curecurrent.com/trials/feasibility-study-of-2000-iu-per-day-of-vitamin-d-for-the-primary-prevention-of-type-1-diabetes-23406https://curecurrent.com/trials/copeptin-in-differentiation-of-polyuria-and-polydipsia-23407https://curecurrent.com/trials/effects-of-exercise-training-on-left-ventricular-function-in-type-2-diabetic-patients-post-coronary-artery-bypass-graft-23408https://curecurrent.com/trials/study-on-the-effects-on-blood-glucose-following-intradermal-and-subcutaneous-dosing-of-insulin-in-diabetic-patients-23409https://curecurrent.com/trials/efficacy-and-safety-of-ursodeoxycholic-acid-udca-added-to-the-dpp-4-inhibitor-in-people-with-type-2-diabetes-and-chronic-23410https://curecurrent.com/trials/effectiveness-study-of-the-guardian-rt-in-type-1-diabetics-23411https://curecurrent.com/trials/effect-of-anakinra-on-insulin-sensitivity-in-type-1-diabetes-mellitus-23412https://curecurrent.com/trials/gene-expression-profiles-and-metformin-efficacy-in-type-2-diabetes-23413https://curecurrent.com/trials/preliminary-assessment-of-the-efficacy-of-the-vascuactive-device-on-diabetic-peripheral-neuropathy-23414https://curecurrent.com/trials/effects-of-intranasal-oxytocin-and-vasopressin-on-social-behavior-23415https://curecurrent.com/trials/vitamin-d-and-inflammatory-markers-of-cardiovascular-disease-in-african-americans-with-type-2-diabetes-23416https://curecurrent.com/trials/autologous-bone-marrow-stem-cell-transplantation-for-critical-limb-threatening-ischemia-23417https://curecurrent.com/trials/effects-of-caloric-restriction-on-fetuin-a-and-cardiovascular-risk-factors-23418https://curecurrent.com/trials/closing-the-loop-for-36-hours-in-adolescents-with-type-1-diabetes-23419https://curecurrent.com/trials/efficacy-and-safety-study-of-ataciguat-versus-placebo-in-patients-with-neuropathic-pain-23420https://curecurrent.com/trials/feasibility-study-to-assess-the-safety-and-functionality-of-the-glusense-continuous-glucose-monitor-in-diabetic-patients-23421https://curecurrent.com/trials/a-long-term-study-for-the-treatment-of-painful-diabetic-neuropathy-23422https://curecurrent.com/trials/implementation-of-an-integrated-primary-care-network-for-prevention-and-management-of-cardiometabolic-risks-23423https://curecurrent.com/trials/b-type-natriuretic-peptide-and-glucose-metabolism-23424https://curecurrent.com/trials/segudiab-study-evaluation-of-safety-in-the-diabetic-patients-23425https://curecurrent.com/trials/insulin-pump-therapy-and-continuous-glucose-monitoring-in-diabetic-continuous-ambulatory-peritoneal-dialysis-capd-patien-23426https://curecurrent.com/trials/safety-and-efficacy-of-mesenchymal-stem-cells-in-newly-diagnosed-type-1-diabetic-patients-23427https://curecurrent.com/trials/the-efficacy-of-specialist-collaboration-and-mobile-screening-for-improving-the-management-of-diabetes-23428https://curecurrent.com/trials/safety-and-efficacy-of-daptomycin-for-the-treatment-of-complicated-skin-and-skin-structure-infections-23429https://curecurrent.com/trials/asian-diabetes-surgery-study-adss-clinical-predictor-for-the-success-of-metabolic-surgery-23430https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-sodium-bemiparin-for-treatment-of-diabetic-foot-ulcers-23431https://curecurrent.com/trials/dietary-antioxidants-redox-tone-and-health-promotion-an-orthomolecular-study-of-interactions-23432https://curecurrent.com/trials/effectiveness-of-sitagliptin-in-glycemic-control-in-real-world-23433https://curecurrent.com/trials/effectiveness-of-precede-model-for-health-education-on-changes-and-level-of-control-in-patients-with-type-2-diabetes-mel-23434https://curecurrent.com/trials/effect-of-sulodexide-on-albuminuria-in-chinese-type-2-diabetic-patients-23435https://curecurrent.com/trials/antidiabetic-properties-of-rose-hip-23436https://curecurrent.com/trials/impact-of-liraglutide-on-endothelial-function-and-microvascular-blood-flow-in-type-2-diabetes-mellitus-23437https://curecurrent.com/trials/effects-of-amlodipine-benazepril-on-albuminuria-in-hypertensive-patients-with-type-2-diabetes-mellitus-23438https://curecurrent.com/trials/study-on-liver-fat-content-and-visceral-fat-mass-in-overweight-and-obese-type-2-diabetes-patients-after-treatment-with-b-23439https://curecurrent.com/trials/postprandial-dysmetabolism-23440https://curecurrent.com/trials/zinc-supplementation-in-type-2-diabetics-23441https://curecurrent.com/trials/the-incretin-effect-in-patients-with-gestational-diabetes-mellitus-23442https://curecurrent.com/trials/the-glycemic-indices-of-five-common-varieties-of-dates-in-the-tested-among-healthy-and-diabetic-subjects-23443https://curecurrent.com/trials/effects-of-heating-massaging-vibrating-vicinity-of-the-insulin-delivery-site-23444https://curecurrent.com/trials/cell-therapy-in-diabetic-patients-with-st-segment-elevation-myocardial-infarction-stemi-23445https://curecurrent.com/trials/a-study-conducted-over-3-periods-to-look-at-the-drug-in-the-body-23446https://curecurrent.com/trials/relative-bioavailability-and-activity-of-different-formulations-of-insulin-glargine-and-lixisenatide-in-patients-with-di-23447https://curecurrent.com/trials/cardiovascular-disease-cvd-in-haemophilia-23448https://curecurrent.com/trials/panretinal-photocoagulation-for-diabetic-retinopathy-with-pascal-laser-23449https://curecurrent.com/trials/efficacy-of-insulin-lispro-mix-50-50-therapy-23450https://curecurrent.com/trials/self-care-behaviour-treatment-in-patients-with-diabetes-a-randomised-controlled-trial-23451https://curecurrent.com/trials/effects-of-alogliptin-on-pancreatic-beta-cell-function-23452https://curecurrent.com/trials/safety-study-of-bms-816336-in-healthy-male-subjects-23453https://curecurrent.com/trials/clinical-trial-to-investigate-the-pharmacokinetics-pharmacodynamics-of-sitagliptin-23454https://curecurrent.com/trials/the-effect-of-chlorella-on-glycemic-control-of-diabetes-23455https://curecurrent.com/trials/reducing-sedentary-behaviour-in-young-adults-at-risk-of-diabetes-23456https://curecurrent.com/trials/feasibility-of-peripheral-angioplasty-in-type-d-tascii-lesions-23457https://curecurrent.com/trials/safety-and-efficacy-of-converting-maintenance-kidney-and-liver-transplant-recipients-with-abnormal-glucose-metabolism-fr-23458https://curecurrent.com/trials/the-effectiveness-of-improving-self-care-after-counseling-for-the-diabetics-mellitus-foots-around-chiayi-region-23459https://curecurrent.com/trials/pharmaceutical-care-in-type-2-diabetes-23460https://curecurrent.com/trials/diacerein-on-insulin-secretion-in-diabetes-23461https://curecurrent.com/trials/dame-induction-of-labor-or-waiting-for-suspicion-fetal-macrosomia-23462https://curecurrent.com/trials/topic-insulin-accelerates-wound-healing-in-diabetes-23463https://curecurrent.com/trials/maintenance-of-effect-of-duloxetine-in-patients-with-diabetic-peripheral-neuropathic-pain-dpnp-23464https://curecurrent.com/trials/characterization-of-the-incretinpathy-in-type-2-diabetes-initiated-after-sixty-years-old-23465https://curecurrent.com/trials/study-to-assess-the-optimal-renoprotective-dose-of-aliskiren-in-hypertensive-patients-with-type-2-diabetes-and-incipient-23466https://curecurrent.com/trials/multiple-dose-escalating-study-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-asp1941-23467https://curecurrent.com/trials/first-in-men-study-of-single-oral-doses-of-asp1941-in-healthy-subjects-23468https://curecurrent.com/trials/conversion-from-tacrolimus-to-cyclosporine-microemulsion-in-liver-transplant-patients-with-new-onset-diabetes-after-the-23469https://curecurrent.com/trials/an-efficacy-and-safety-study-of-cisapride-for-improving-symptoms-associated-with-gastroparesis-in-patients-with-diabetes-23470https://curecurrent.com/trials/initiation-and-titration-of-amaryl-23471https://curecurrent.com/trials/study-to-optimize-insulin-treatment-by-basal-regimen-with-insulin-glargine-in-type-2-diabetic-patients-previously-uncont-23472https://curecurrent.com/trials/detection-of-vascular-injury-in-diabetes-through-eye-and-nailfold-data-dividend-a-pilot-study-23473https://curecurrent.com/trials/optimal-oral-hypoglycaemic-agents-oha-for-combination-with-insulin-glargine-sulfonylurea-vs-metformin-23474https://curecurrent.com/trials/insulin-resistance-as-primary-pathogenesis-in-newly-diagnosed-drug-na-ve-type-2-diabetes-patients-in-korea-23475https://curecurrent.com/trials/effect-of-glp-1-and-gip-on-insulin-secretion-in-type-1-diabetes-mellitus-23476https://curecurrent.com/trials/study-of-enbrel-in-rheumatoid-arthritis-ra-subjects-with-comorbid-disorders-23477https://curecurrent.com/trials/effect-of-glp-1-on-insulin-dose-risk-of-hypoglycemia-and-gastric-emptying-rate-in-patients-with-type-1-diabetes-23478https://curecurrent.com/trials/hyperglycemia-and-cardiovascular-outcomes-with-type-2-diabetes-23479https://curecurrent.com/trials/glucose-tolerance-in-patients-with-an-idiopathic-parkinson-s-disease-23480https://curecurrent.com/trials/efficacy-and-safety-study-of-laparoscopic-roux-en-y-gastric-bypass-lrygb-to-treat-type-2-diabetes-mellitus-23481https://curecurrent.com/trials/therapeutic-lifestyle-modifications-to-reduce-burden-of-chronic-disease-23482https://curecurrent.com/trials/glycemic-index-and-polyphenol-bioavailability-of-potatoes-23483https://curecurrent.com/trials/study-to-prevent-diabetes-with-short-term-insulin-glargine-only-23484https://curecurrent.com/trials/the-effect-of-hyperglycaemia-on-local-energy-stores-in-the-working-muscle-in-patients-with-type-1-diabetes-mellitus-23485https://curecurrent.com/trials/natural-history-of-pedal-puncture-wounds-in-diabetics-23486https://curecurrent.com/trials/tulip-study-testing-the-usefulness-of-lantus-when-initiated-prematurely-in-patients-with-type-2-diabetes-23487https://curecurrent.com/trials/analysis-of-the-effect-of-intravitreal-dexamethasone-injection-on-diabetic-macular-edema-after-cataract-surgery-iddmecs-23488https://curecurrent.com/trials/variable-bolus-regimen-1-2-3-for-type-2-diabetes-mellitus-23489https://curecurrent.com/trials/type-2-diabetes-haptoglobin-phenotype-and-vitamin-e-23490https://curecurrent.com/trials/study-of-postprandial-incretin-response-in-women-with-gestational-diabetes-23491https://curecurrent.com/trials/insulin-glargine-in-type-2-diabetes-23492https://curecurrent.com/trials/insulin-glulisine-in-type-2-diabetes-mellitus-23493https://curecurrent.com/trials/an-investigation-on-the-effect-of-candesartan-on-early-diabetic-nephropathy-23494https://curecurrent.com/trials/basal-analog-study-comparison-of-lantus-or-levemir-with-nph-insulin-from-t1dm-diagnosis-23495https://curecurrent.com/trials/thiazolidinedione-tzd-on-the-diabetic-retinopathy-and-nephropathy-23496https://curecurrent.com/trials/improving-secretion-of-insulin-in-new-onset-diabetes-after-renal-transplantation-23497https://curecurrent.com/trials/personalized-medicine-for-diabetes-prediction-and-prevention-of-complications-23498https://curecurrent.com/trials/ast-clinical-investigation-23499https://curecurrent.com/trials/efficacy-and-safety-of-firebird-2-stent-in-treatment-of-complex-coronary-lesions-in-diabetes-23500https://curecurrent.com/trials/pharmacological-intervention-in-diabetic-retinopathy-23501https://curecurrent.com/trials/a-pharmacokinetic-evaluation-of-metformin-in-relation-to-the-polymorphism-a270s-in-healthy-caucasian-volunteers-23502https://curecurrent.com/trials/prevent-delay-development-of-type-2-diabetes-in-subjects-with-impaired-glucose-homeostasis-treated-with-acarbose-in-prim-23503https://curecurrent.com/trials/exercise-consultation-for-type-2-diabetes-patients-in-real-life-23504https://curecurrent.com/trials/safety-study-of-th9507-in-subjects-with-stable-type-2-diabetes-23505https://curecurrent.com/trials/interleukin-1-receptor-antagonist-and-insulin-sensitivity-23506https://curecurrent.com/trials/synbiotics-and-low-grade-inflammation-in-obese-subjects-23507https://curecurrent.com/trials/prevention-of-gestational-diabetes-23508https://curecurrent.com/trials/efficacy-and-safety-study-of-dermagen-vs-conventional-treatment-to-treat-diabetic-neuropathic-foot-ulcer-23509https://curecurrent.com/trials/reassure-the-effect-of-rimonabant-on-hba1c-in-overweight-or-obese-patients-with-type-2-diabetes-not-adequately-controlle-23510https://curecurrent.com/trials/evaluation-of-the-rimonabant-impact-on-the-regression-of-asymptomatic-damage-caused-by-cardiovascular-risk-factors-23511https://curecurrent.com/trials/observational-study-in-japanese-type-2-diabetes-patients-23512https://curecurrent.com/trials/insulin-dependent-gestational-diabetes-mellitus-randomized-trial-of-induction-of-labour-at-38-and-40-weeks-of-gestation-23513https://curecurrent.com/trials/patients-with-type-2-diabetes-mellitus-with-insufficient-glycaemic-control-despite-treatment-with-metformin-alone-or-met-23514https://curecurrent.com/trials/the-electroretinogram-in-healthy-and-glucose-intolerant-young-men-23515https://curecurrent.com/trials/measuring-retinal-vessel-caliber-in-relation-to-dark-adaptation-and-blood-glucose-level-23516https://curecurrent.com/trials/the-effect-of-oral-hygiene-and-full-mouth-scaling-on-metabolic-control-in-patients-with-type-ii-diabetes-23517https://curecurrent.com/trials/possible-epigenetic-changes-in-offspring-of-women-with-pregestational-and-gestational-diabetes-23518https://curecurrent.com/trials/single-ascending-dose-study-with-healthy-male-volunteers-and-type-ii-diabetic-patients-23519https://curecurrent.com/trials/effect-of-gynostemma-pentaphyllum-tea-in-insulin-sensitivity-in-type-2-diabetic-patients-23520https://curecurrent.com/trials/glulisine-pre-and-postmeal-23521https://curecurrent.com/trials/anti-diabetic-effect-of-gynostemma-pentaphyllum-tea-as-add-on-therapy-with-sulfonylureas-in-type-2-diabetic-patients-23522https://curecurrent.com/trials/anti-diabetic-effect-of-gynostemma-pentaphyllum-tea-in-type-2-diabetic-patients-23523https://curecurrent.com/trials/single-centre-randomised-double-blind-placebo-controlled-four-way-crossover-clinical-study-to-investigate-safety-and-tol-23524https://curecurrent.com/trials/hypertensive-treatment-pattern-survey-for-type-ii-diabetes-mellitus-patients-with-complication-and-hypertension-23525https://curecurrent.com/trials/si-yo-puedo-control-mi-diabetes-a-diabetes-self-management-education-program-for-hispanic-latinos-23526https://curecurrent.com/trials/retrospective-survey-for-patients-with-hypertension-and-diabetes-mellitus-23527https://curecurrent.com/trials/comparison-of-autologous-mesenchymal-stem-cells-and-mononuclear-cells-on-diabetic-critical-limb-ischemia-and-foot-ulcer-23528https://curecurrent.com/trials/type-2-diabetes-mellitus-collaborative-genetic-study-on-non-aboriginal-taiwanese-23529https://curecurrent.com/trials/chronic-reduction-of-fasting-glycaemia-with-insulin-glargine-improves-first-and-second-phase-insulin-secretion-in-patien-23530https://curecurrent.com/trials/group-lifestyle-intervention-for-people-with-new-onset-type-2-diabetes-23531https://curecurrent.com/trials/sugarsquare-focus-on-the-adolescent-digital-treatment-of-type-1-diabetes-through-the-internet-23532https://curecurrent.com/trials/superiority-of-glimepiride-over-sitagliptin-in-naive-type-2-diabetes-patients-23533https://curecurrent.com/trials/exercise-and-acarbose-in-type-2-diabetes-23534https://curecurrent.com/trials/a-phase-iii-randomized-double-blind-parallel-group-study-to-evaluate-the-efficacy-and-safety-of-acarmet-metformin-hcl-50-23535https://curecurrent.com/trials/dialoog-crestor-in-patients-with-diabetes-mellitus-type-2-lowering-of-ldl-c-levels-to-new-european-guidelines-23536https://curecurrent.com/trials/skin-and-retina-microvascular-endothelial-function-in-healthy-insulin-resistant-and-type-2-diabetic-subjects-23537https://curecurrent.com/trials/pharmacogenetic-effect-on-the-pharmacodynamics-of-glibenclamide-23538https://curecurrent.com/trials/the-effects-of-a-regenerative-mitochondrial-medication-on-physiological-parameters-in-case-of-diabetes-mellitus-type-ii-23539https://curecurrent.com/trials/korean-amadeus-study-23540https://curecurrent.com/trials/investigate-the-effect-of-azd1656-on-the-pharmacokinetics-and-pharmacodynamics-of-warfarin-in-type-2-diabetes-mellitus-t-23541https://curecurrent.com/trials/therapeutic-exploratory-study-of-cwp-0403-23542https://curecurrent.com/trials/vildagliptin-and-endothelium-dependent-vasodilatation-23543https://curecurrent.com/trials/assessment-of-insulin-glargine-in-type-2-patients-for-good-glycemic-control-23544https://curecurrent.com/trials/the-effect-of-an-alginate-based-beverage-on-weight-loss-23545https://curecurrent.com/trials/antiproteinuric-effect-of-imidapril-versus-ramipril-in-type-2-diabetic-and-hypertensive-patients-with-microalbuminuria-23546https://curecurrent.com/trials/korea-national-diabetes-program-23547https://curecurrent.com/trials/fish-gelatin-supplement-and-omega-3-supplement-in-obese-or-overweight-subjects-with-insulin-resistance-23548https://curecurrent.com/trials/brown-rice-intervention-on-metabolic-syndrome-brims-23549https://curecurrent.com/trials/diagnosis-of-coronary-artery-disease-in-high-risk-diabetic-patients-23550https://curecurrent.com/trials/food-and-gastrointestinal-habits-after-bariatric-surgery-23551https://curecurrent.com/trials/collection-of-information-rich-type-1-diabetes-data-23552https://curecurrent.com/trials/exercise-training-intervention-in-children-with-type-1-diabetes-23553https://curecurrent.com/trials/bioequivalence-study-of-metformin-hydrochloride-extended-release-750-mg-tablets-versus-glucophage-xr-750-mg-tablet-in-he-23554https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-injection-for-diabetic-foot-23555https://curecurrent.com/trials/a-study-for-patients-with-type-1-diabetes-mellitus-23556https://curecurrent.com/trials/umbilical-cord-mesenchymal-stem-cells-infusion-for-initial-type-1-diabetes-mellitus-23557https://curecurrent.com/trials/secondary-prevention-in-type-2-diabetes-comparison-of-two-different-resistance-exercise-training-protocols-23558https://curecurrent.com/trials/diabetes-in-charge-trial-of-diabetes-intervention-in-the-community-to-help-achieve-reduced-glucose-elevation-23559https://curecurrent.com/trials/orthostatic-hypotension-and-diabetes-mellitus-23560https://curecurrent.com/trials/efficacy-of-pioglitazone-metformin-combination-therapy-in-subjects-with-type-2-diabetes-mellitus-and-dyslipidemia-23561https://curecurrent.com/trials/olmesartan-and-calcium-antagonists-randomized-oscar-study-23562https://curecurrent.com/trials/a-study-to-determine-the-absorption-of-peroral-insulin-in-dextran-matrix-ora3-23563https://curecurrent.com/trials/a-two-part-study-of-peroral-insulin-in-type-2-diabetes-23564https://curecurrent.com/trials/1-5-ag-as-a-marker-of-postprandial-hyperglycemia-and-glucose-variability-in-well-controlled-type-2-diabetes-mellitus-23565https://curecurrent.com/trials/study-of-olmesartan-medoxomil-cs-866-in-patients-with-chronic-glomerulonephritis-or-diabetic-nephropathy-23566https://curecurrent.com/trials/efficacy-of-dlbs-32-in-subjects-with-type-ii-diabetes-mellitus-23567https://curecurrent.com/trials/carpal-tunnel-release-in-diabetic-patients-23568https://curecurrent.com/trials/effect-of-alpha-lipoic-acid-on-obesity-related-comorbidities-23569https://curecurrent.com/trials/clinical-trial-on-alpha-lipoic-acid-in-diabetic-macular-edema-23570https://curecurrent.com/trials/investigation-of-a-switch-from-insulin-therapy-to-a-metformin-saxagliptin-combination-in-patients-with-type-2-diabetes-m-23571https://curecurrent.com/trials/beta-cell-relieving-and-cardiovascular-protective-effects-of-lantus-treatment-in-type-2-diabetes-patients-23572https://curecurrent.com/trials/a-study-for-type-2-diabetic-patients-23573https://curecurrent.com/trials/triple-therapy-of-pars-plana-vitrectomy-and-grid-focal-laser-for-diabetic-macular-edema-dme-23574https://curecurrent.com/trials/ranibizumab-for-diabetic-traction-retinal-detachment-23575https://curecurrent.com/trials/topical-autologous-serum-application-for-the-treatment-of-corneal-epithelium-defect-after-ocular-surgeries-23576https://curecurrent.com/trials/study-of-safety-and-effectiveness-of-apidra-in-combination-with-basal-insulin-in-patients-with-type-1-2-diabetes-mellitu-23577https://curecurrent.com/trials/safety-tolerability-and-effect-of-ly2405319-after-multiple-injections-in-subjects-with-type-2-diabetes-23578https://curecurrent.com/trials/domme-dose-optimization-multicentric-mexican-evaluation-23579https://curecurrent.com/trials/an-open-randomized-balanced-crossover-bioequivalence-study-to-compare-one-mr-tablet-of-60-mg-gliclazide-and-two-mr-table-23580https://curecurrent.com/trials/low-glycemic-index-diet-in-patients-with-type-1-diabetes-23581https://curecurrent.com/trials/insulin-administration-plus-a-telemedicine-system-diabetes-interactive-diary-did-vs-insulin-plus-common-practice-23582https://curecurrent.com/trials/controlled-study-to-evaluate-efficacy-and-safety-of-ka-tab-with-low-protein-diet-lpd-in-delaying-the-progress-of-type-2-23583https://curecurrent.com/trials/efficacy-of-pioglitazone-and-insulin-in-treating-subjects-with-type-2-diabetes-mellitus-and-renal-failure-23584https://curecurrent.com/trials/the-ascend-study-a-study-to-investigate-the-safety-and-clinical-effect-of-nexagon-to-treat-slow-healing-diabetic-foot-ul-23585https://curecurrent.com/trials/a-trial-comparing-lantus-algorithms-to-achieve-normal-blood-glucose-targets-in-subjects-with-uncontrolled-blood-sugar-wi-23586https://curecurrent.com/trials/psychosocial-interventions-in-the-treatment-of-youth-with-type-1-diabetes-mellitus-23587https://curecurrent.com/trials/insulin-glargine-in-type-i-diabetes-mellitus-main-study-at-lantus-a-trial-comparing-lantus-algorithms-to-achieve-normal-23588https://curecurrent.com/trials/insulin-analogue-with-continuous-glucose-monitoring-system-cgms-measurement-23589https://curecurrent.com/trials/four-hour-evaluation-of-a-medical-food-in-subjects-with-type-2-diabetes-23590https://curecurrent.com/trials/prevention-of-postprandial-hyperglycemia-by-acarbose-may-be-a-promising-therapeutic-strategy-for-reducing-the-increased-23591https://curecurrent.com/trials/computer-assisted-cancer-risk-behavior-counseling-23592https://curecurrent.com/trials/a-phase-iia-proof-of-concept-study-of-nc-503-in-patients-with-type-ii-diabetes-23593https://curecurrent.com/trials/the-effect-and-mechanisms-of-the-second-meal-phenomenon-in-type-2-diabetic-patients-23594https://curecurrent.com/trials/study-to-compare-the-effect-of-vytorin-simvastatin-ezetimibe-10-20mg-versus-atorvastatin-20mg-on-apob-apoa1-ratio-in-sub-23595https://curecurrent.com/trials/management-of-diabetes-mellitus-patients-with-retinopathy-23596https://curecurrent.com/trials/efficacy-of-pioglitazone-and-metformin-on-cardiovascular-risk-in-subjects-with-insulin-treated-type-2-diabetes-mellitus-23597https://curecurrent.com/trials/endothelial-effects-of-basal-insulin-detemir-versus-glargine-23598https://curecurrent.com/trials/evaluation-of-diabetes-care-at-austrian-gps-23599https://curecurrent.com/trials/genetic-variation-in-oct1-and-response-to-metformin-23600https://curecurrent.com/trials/lacidipine-in-mild-to-moderate-essential-hypertension-patients-with-type-2-diabetes-in-korea-23601https://curecurrent.com/trials/research-on-the-correlation-among-magnetocardiography-patterns-and-known-cardiovascular-risk-factors-in-diabetic-patient-23602https://curecurrent.com/trials/functional-imaging-of-the-therapeutic-effect-of-pregabalin-in-treatment-for-neuropathic-pain-23603https://curecurrent.com/trials/efficacy-and-safety-of-lodenafil-carbonate-in-the-treatment-of-erectile-dysfunction-in-patients-with-diabetes-23604https://curecurrent.com/trials/effect-of-alcohol-on-cephalic-phase-reflex-and-gene-expression-23605https://curecurrent.com/trials/the-effects-of-breakfast-size-on-hormonal-profile-in-adults-with-type-2-diabetes-mellitus-23606https://curecurrent.com/trials/role-of-self-monitoring-of-blood-glucose-and-intensive-education-in-patients-with-type-2-diabetes-not-receiving-insulin-23607https://curecurrent.com/trials/carbohydrate-counting-in-adults-with-type-1-diabetes-treated-with-continuous-subcutaneous-insulin-infusion-23608https://curecurrent.com/trials/effect-of-atypical-antipsychotic-drugs-olanzapine-and-amisulpride-on-glucose-metabolism-23609https://curecurrent.com/trials/the-impact-of-vitamins-and-minerals-supplementation-on-neuropathy-and-nephropathy-complications-23610https://curecurrent.com/trials/comparison-of-nutritional-products-for-people-with-type-2-diabetes-23611https://curecurrent.com/trials/comparison-safety-and-efficacy-of-basal-insulin-lantus-insulin-glargine-vs-nph-insulin-in-combination-with-oral-antidiab-23612https://curecurrent.com/trials/bioequivalence-study-of-metformin-hydrochloride-extended-release-750-mg-tablets-versus-glucophage-xr-750-mg-tablet-in-he-23613https://curecurrent.com/trials/intrapartum-maternal-glycemic-control-using-insulin-pump-versus-insulin-drip-cohort-observational-trial-23614https://curecurrent.com/trials/a-study-on-the-prevalence-of-obstructive-sleep-apnea-in-patients-with-type-ii-diabetes-mellitus-23615https://curecurrent.com/trials/impact-of-a-computerized-guidelines-on-the-management-of-hypertension-and-diabetes-23616https://curecurrent.com/trials/rosiglitazone-metformin-combination-versus-metformin-sulfonylurea-combination-on-beta-cell-function-in-type-2-diabetes-23617https://curecurrent.com/trials/effects-of-black-tea-on-type-2-diabetes-23618https://curecurrent.com/trials/study-of-cellular-impairments-involved-in-diabetic-complications-23619https://curecurrent.com/trials/the-benefits-of-intensive-glycemic-control-in-elderly-patients-with-type-2-diabetes-23620https://curecurrent.com/trials/efficacy-and-safety-of-treatment-with-balaglitazone-in-type-2-diabetes-patients-on-stable-insulin-therapy-23621https://curecurrent.com/trials/treatment-of-type-2-diabetes-mellitus-by-duodenal-exclusion-associated-with-omentectomy-clinical-and-hormonal-study-23622https://curecurrent.com/trials/innovative-strategies-for-risk-reduction-following-cabg-23623https://curecurrent.com/trials/microcirculation-assessment-in-diabetes-and-metabolic-syndrome-23624https://curecurrent.com/trials/surgical-treatment-of-non-obese-type-2-diabetic-patients-with-duodenal-exclusion-23625https://curecurrent.com/trials/lispro-mid-mixture-mm-intensive-mixture-therapy-with-progressive-dose-titration-of-lispro-low-mixture-lm-or-biphasic-ins-23626https://curecurrent.com/trials/pharmacodynamic-and-pharmacokinetic-effects-of-insulin-glulisine-in-obese-subjects-with-type-2-diabetes-after-a-standard-23627https://curecurrent.com/trials/influence-of-dpp-4-on-inflammatory-parameters-in-diabetics-gender-aspects-23628https://curecurrent.com/trials/effects-of-different-exercise-training-dose-on-exercise-performance-and-noninvasively-estimated-muscle-oxygen-extraction-23629https://curecurrent.com/trials/herbal-preparation-used-as-adjuvant-therapy-on-diabetic-ulcers-23630https://curecurrent.com/trials/role-of-dietary-fatty-acids-in-fatty-liver-and-insulin-resistance-23631https://curecurrent.com/trials/metabolic-effects-of-vitamin-d-in-patients-with-type-2-diabetes-23632https://curecurrent.com/trials/comparison-of-coronary-xience-v-and-the-cypher-select-stents-in-diabetic-patients-23633https://curecurrent.com/trials/effect-of-spinal-cord-stimulation-in-painful-diabetic-polyneuropathy-23634https://curecurrent.com/trials/efficacy-and-safety-study-of-pioglitazone-combined-with-metformin-on-metabolic-syndrome-in-subjects-with-type-2-diabetes-23635https://curecurrent.com/trials/efficacy-of-pioglitazone-and-glimepiride-combination-therapy-in-treating-subjects-with-type-2-diabetes-mellitus-23636https://curecurrent.com/trials/efficacy-of-pioglitazone-on-myocardial-function-in-patients-undergoing-coronary-stent-implantation-23637https://curecurrent.com/trials/efficacy-of-pioglitazone-and-fortamet-combination-therapy-in-subjects-with-type-2-diabetes-23638https://curecurrent.com/trials/efficacy-study-of-pioglitazone-and-atorvastatin-combination-therapy-in-treating-subjects-with-elevated-risk-for-cardiova-23639https://curecurrent.com/trials/to-evaluate-the-effect-of-gemfibrozil-on-the-pharmacokinetics-and-pharmacodynamics-of-a-single-dose-of-azd1656-23640https://curecurrent.com/trials/investigate-the-effect-of-azd1656-on-the-pharmacokinetics-of-sitagliptin-in-patients-with-type-2-diabetes-mellitus-23641https://curecurrent.com/trials/implementation-of-a-diabetes-management-protocol-as-compared-to-conventional-management-in-a-heart-hospital-s-non-intens-23642https://curecurrent.com/trials/personality-of-diabetic-patients-will-influence-their-medical-compliance-a-5-years-cohort-follow-up-with-type-d-personal-23643https://curecurrent.com/trials/mechanism-of-fatty-acid-induced-impairment-of-glucose-simulated-insulin-secretion-effect-of-buphenyl-23644https://curecurrent.com/trials/efficacy-of-candesartan-on-symptomatic-heart-failure-in-treating-diabetic-and-hypertensive-patients-23645https://curecurrent.com/trials/effect-of-pulse-fractions-on-indices-on-cardiovascular-disease-and-diabetes-risk-factors-23646https://curecurrent.com/trials/study-to-compare-the-bioavailability-of-extended-release-metformin-hcl-tablet-versus-glucophage-xr-tablets-in-healthy-hu-23647https://curecurrent.com/trials/i-am-able-population-based-rehabilitation-in-a-family-health-team-23648https://curecurrent.com/trials/effects-of-six-months-of-moderate-resistance-versus-endurance-training-on-muscle-atp-synthesis-in-first-degree-relatives-23649https://curecurrent.com/trials/various-insulin-regimens-for-diabetic-inpatients-with-cirrhosis-trial-23650https://curecurrent.com/trials/stem-cell-therapy-for-type-1-diabetes-mellitus-23651https://curecurrent.com/trials/validation-study-of-g4-user-interface-23652https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-tak-875-in-subjects-with-type-2-diabetes-23653https://curecurrent.com/trials/stem-cell-therapy-for-type-2-diabetes-mellitus-23654https://curecurrent.com/trials/progression-to-impaired-glucose-tolerance-and-type-2-diabetes-in-the-korean-people-based-kndp-study-23655https://curecurrent.com/trials/efficacy-of-surgical-treatment-of-osteomyelitis-in-diabetic-foot-ulcers-23656https://curecurrent.com/trials/cilostazol-versus-aspirin-for-primary-prevention-of-atherosclerotic-events-23657https://curecurrent.com/trials/effects-of-exercise-behavior-modification-on-plasma-adiponectin-and-insulin-resistance-in-high-risk-subjects-of-diabetes-23658https://curecurrent.com/trials/performance-study-using-the-optiscanner-on-healthy-diabetics-23659https://curecurrent.com/trials/type-2-diabetes-management-with-lantus-malbec-manejo-con-lantus-de-diab-ticos-tipo-2-23660https://curecurrent.com/trials/transplantation-of-pancreatic-islets-in-patients-with-type-1-diabetes-mellitus-and-functional-kidney-graft-23661https://curecurrent.com/trials/prevalence-of-diabetic-retinopathy-in-s-o-jos-do-rio-preto-sp-brazil-23662https://curecurrent.com/trials/treat-arterial-hypertension-and-diabetes-in-rural-africa-23663https://curecurrent.com/trials/to-compare-the-efficacy-and-safety-of-tripterygium-tw-versus-valsartan-in-the-diabetic-nephropathy-dn-23664https://curecurrent.com/trials/study-on-dmmet-01-versus-metformin-on-improvement-of-metabolic-control-in-naive-type-2-diabetes-patients-23665https://curecurrent.com/trials/effect-of-oral-combination-therapy-in-a-single-dosage-form-in-patients-with-type-2-diabetes-mellitus-23666https://curecurrent.com/trials/effects-of-acarbose-versus-glibenclamide-on-mage-and-oxidative-stress-in-patients-with-type-2-dm-23667https://curecurrent.com/trials/short-term-effect-of-intensive-insulin-therapy-on-incretin-secretion-23668https://curecurrent.com/trials/closing-the-loop-in-adults-with-type-1-diabetes-alcohol-consumption-23669https://curecurrent.com/trials/h-meenlinna-metabolic-syndrome-research-program-surrogate-indicators-for-atherosclerosis-23670https://curecurrent.com/trials/efficacy-of-calcitriol-in-recent-onset-type-1-diabetes-23671https://curecurrent.com/trials/bioequivalence-study-of-metformin-hydrochloride-extended-release-500-mg-tablet-versus-glucophage-xr-500-mg-tablet-in-hea-23672https://curecurrent.com/trials/supervised-walking-groups-as-a-model-to-increase-physical-activity-in-type-2-diabetes-23673https://curecurrent.com/trials/giant-general-practitioner-implementation-in-asia-of-normoglycaemic-targets-23674https://curecurrent.com/trials/single-dose-dose-escalation-study-of-safety-pk-and-preliminary-efficacy-of-xoma-052-in-type-2-diabetes-mellitus-23675https://curecurrent.com/trials/h-meenlinna-metabolic-syndrome-research-program-oxidized-ldl-and-arterial-elasticity-in-metabolic-syndrome-and-controls-23676https://curecurrent.com/trials/babydiet-study-primary-prevention-of-type-1-diabetes-in-relatives-at-increased-genetic-risk-23677https://curecurrent.com/trials/severe-proliferative-diabetic-retinopathy-23678https://curecurrent.com/trials/a-study-on-efficacy-and-safety-of-topiramate-in-the-treatment-of-patients-with-obesity-23679https://curecurrent.com/trials/first-in-man-study-with-slv341-23680https://curecurrent.com/trials/a-study-on-efficacy-and-safety-of-topiramate-in-maintaining-weight-loss-in-obese-patients-following-an-intensive-non-pha-23681https://curecurrent.com/trials/quality-of-life-and-treatment-satisfaction-of-people-with-type-2-diabetes-a-european-survey-23682https://curecurrent.com/trials/early-insulin-treatment-in-patients-with-latent-autoimmune-diabetes-23683https://curecurrent.com/trials/postprandial-inflammation-and-fatty-acids-23684https://curecurrent.com/trials/trial-of-tang-min-ling-pills-in-the-treatment-of-type-2-diabetes-23685https://curecurrent.com/trials/associations-between-diabetes-arterial-stiffness-and-fibulin-1-in-patients-undergoing-heart-and-vascular-surgery-23686https://curecurrent.com/trials/blood-retinal-barrier-imaging-and-neuropsychiatric-sequela-in-type-2-diabetes-mellitus-23687https://curecurrent.com/trials/fenofibrate-and-metformin-fixed-combination-vs-metformin-fame-metfo-23688https://curecurrent.com/trials/effect-of-simvastatin-and-ezetimibe-on-lipid-and-inflammation-23689https://curecurrent.com/trials/18-week-add-on-to-metformin-comparison-of-saxagliptin-and-sitagliptin-in-adult-patients-with-type-2-diabetes-t2d-23690https://curecurrent.com/trials/the-effectiveness-of-photographic-educational-material-on-carbohydrate-counting-for-adolescents-with-diabetes-23691https://curecurrent.com/trials/characterization-of-low-density-lipoprotein-and-mechanism-of-the-pro-aggregant-effect-through-oxidant-stress-and-lipid-e-23692https://curecurrent.com/trials/a-study-for-the-treatment-of-diabetic-peripheral-neuropathic-pain-23693https://curecurrent.com/trials/a-trial-of-one-to-one-weight-management-in-primary-care-23694https://curecurrent.com/trials/renal-and-hormonal-effects-of-pioglitazone-23695https://curecurrent.com/trials/high-sensitivity-c-reactive-protein-and-united-kingdom-prospective-diabetes-study-ukpds-risk-score-in-type-2-diabetes-23696https://curecurrent.com/trials/effects-of-rituximab-and-mycophenolate-mofetil-mmf-on-highly-sensitized-patients-awaiting-renal-transplant-23697https://curecurrent.com/trials/stress-management-therapy-for-meniere-s-disease-23698https://curecurrent.com/trials/effect-of-sitagliptin-on-endothelial-progenitor-cells-23699https://curecurrent.com/trials/vascular-effects-of-sitagliptin-in-diabetes-mellitus-23700https://curecurrent.com/trials/multicentric-prospective-randomized-trial-on-surgery-versus-standard-medical-care-in-type-2-diabetic-patients-bmi-30-35-23701https://curecurrent.com/trials/crestor-rapid-the-efficacy-of-rosuvastatin-for-korean-dyslipidemia-patients-with-diabetes-23702https://curecurrent.com/trials/testosterone-for-men-with-insulin-treated-type-2-diabetes-23703https://curecurrent.com/trials/testosterone-replacement-in-diabetes-with-vascular-disease-version-2-23704https://curecurrent.com/trials/electrodiagnostic-parameters-in-patients-with-impaired-glucose-tolerance-and-diabetes-mellitus-23705https://curecurrent.com/trials/the-body-constitution-and-quality-of-life-of-diabetic-23706https://curecurrent.com/trials/rehabilitation-of-type-2-diabetes-patients-23707https://curecurrent.com/trials/urokinase-therapy-in-diabetic-foot-syndrome-23708https://curecurrent.com/trials/effects-of-periodontal-therapy-on-systemic-inflammation-23709https://curecurrent.com/trials/adjuvant-intravitreal-bevacizumab-in-pars-plana-vitrectomy-for-vitreous-hemorrhage-23710https://curecurrent.com/trials/creatine-supplementation-and-diabetes-23711https://curecurrent.com/trials/lifestyle-intervention-for-effective-diabetes-management-23712https://curecurrent.com/trials/metformin-in-overweight-type-2-diabetes-mellitus-23713https://curecurrent.com/trials/risk-factors-for-diabetes-after-stem-cell-transplantation-23714https://curecurrent.com/trials/risk-factors-for-foot-ulceration-in-the-chronic-kidney-disease-ckd-population-23715https://curecurrent.com/trials/association-study-of-genetic-polymorphisms-of-candidate-genes-with-thiazolidinedione-related-peripheral-edema-and-drug-r-23716https://curecurrent.com/trials/joint-application-of-human-insulin-and-rapid-insulin-analogue-in-control-of-postprandial-glycemia-23717https://curecurrent.com/trials/a-methodological-study-to-evaluate-the-effects-of-single-oral-doses-of-pioglitazone-45-mg-and-rosiglitazone-8-mg-on-sodi-23718https://curecurrent.com/trials/metformin-versus-insulin-in-the-treatment-of-gestational-diabetes-mellitus-23719https://curecurrent.com/trials/an-observational-study-evaluating-patient-satisfaction-and-quality-of-life-associated-with-switching-insulin-23720https://curecurrent.com/trials/clinical-trail-of-tang-min-ling-pills-in-type-2-diabetes-mellitus-23721https://curecurrent.com/trials/using-sugar-water-to-relieve-pain-in-infants-23722https://curecurrent.com/trials/does-green-tea-affect-postprandial-glucose-insulin-and-satiety-in-healthy-subjects-23723https://curecurrent.com/trials/reinforcement-of-the-impact-of-a-functional-insulin-therapy-training-course-by-telemonotoring-with-a-pda-phone-in-type-1-23724https://curecurrent.com/trials/corneal-endothelium-morphology-and-central-thickness-in-type-ii-diabetes-mellitus-and-normal-subjects-23725https://curecurrent.com/trials/pharmacokinetics-dynamics-of-basal-continuous-insulin-infusion-administered-either-intradermally-or-subcutaneously-23726https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-multiple-doses-of-jnj-38431055-in-v-23727https://curecurrent.com/trials/corneal-endothelial-changes-associated-with-phacoemulsification-in-diabetes-mellitus-type-ii-23728https://curecurrent.com/trials/a-self-care-intervention-for-latino-adults-with-diabetes-23729https://curecurrent.com/trials/experimental-studies-of-the-effects-of-caffeine-on-glucose-regulation-23730https://curecurrent.com/trials/consultations-in-adapted-physical-activity-on-behaviours-in-physical-exercise-by-type-2-diabetics-23731https://curecurrent.com/trials/dietetic-intervention-with-soluble-fiber-in-type-2-diabetes-mellitus-dm-patients-with-metabolic-syndrome-ms-23732https://curecurrent.com/trials/detect-diabetes-cardiovascular-risk-evaluation-targets-and-essential-data-for-commitment-of-treatment-23733https://curecurrent.com/trials/asian-study-on-cilostazol-effectivity-in-neuropathies-of-diabetes-mellitus-type-2-a-pilot-study-in-the-philippines-23734https://curecurrent.com/trials/randomised-controlled-trial-of-structured-personal-care-of-type-2-diabetes-mellitus-23735https://curecurrent.com/trials/study-comparing-pitavastatin-and-atorvastatin-in-patients-with-type-ii-diabetes-mellitus-and-combined-dyslipidemia-23736https://curecurrent.com/trials/the-effects-of-metformin-on-pregnancy-and-miscarriage-rates-in-polycystic-ovary-syndrome-pcos-23737https://curecurrent.com/trials/metabolic-response-of-slow-released-carbohydrates-in-diabetes-mellitus-23738https://curecurrent.com/trials/oatmeal-and-insulin-resistance-oma-ir-23739https://curecurrent.com/trials/glycemic-relapse-prevention-maintenance-dose-assessment-23740https://curecurrent.com/trials/psychosocial-treatment-intervention-in-persons-newly-diagnosed-with-rheumatoid-arthritis-or-diabetes-23741https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-ppb-r-203-based-meal-versus-tk9-based-meal-in-20-patients-with-diabetes-23742https://curecurrent.com/trials/bolus-insulin-card-calculator-randomised-controlled-study-23743https://curecurrent.com/trials/international-navigator-hypoglycaemia-study-23744https://curecurrent.com/trials/diabetes-drug-eluting-sirolimus-stent-experience-in-restenosis-trial-23745https://curecurrent.com/trials/terlipressin-in-septic-shock-effects-on-microcirculation-23746https://curecurrent.com/trials/glucose-clamp-study-to-prove-hypo-and-hyperglycemic-episodes-using-a-non-invasive-glucose-monitoring-device-23747https://curecurrent.com/trials/follow-on-study-of-pitavastatin-versus-atorvastatin-in-patients-with-type-ii-diabetes-mellitus-and-combined-dyslipidemia-23748https://curecurrent.com/trials/pre-transplant-rapamycin-treatment-in-islet-transplantation-alone-23749https://curecurrent.com/trials/yukon-choice-versus-taxus-libert-in-diabetes-mellitus-23750https://curecurrent.com/trials/semi-automatic-response-system-sars-in-type-2-diabetes-23751https://curecurrent.com/trials/changes-in-serum-electrolytes-at-different-glucose-concentrations-impact-on-a-non-invasive-glucose-monitoring-method-23752https://curecurrent.com/trials/a-prospective-study-on-diabetes-management-through-an-integrated-delivery-system-23753https://curecurrent.com/trials/of-patient-education-related-to-cv-risk-factors-in-type-2-diabetes-mellitus-patrol-23754https://curecurrent.com/trials/effects-of-atazanavir-treatment-on-type-2-diabetes-mellitus-related-endothelial-dysfunction-23755https://curecurrent.com/trials/efficacy-and-safety-study-of-soluble-beta-1-3-1-6-glucan-sbg-versus-placebo-in-chronic-diabetic-foot-ulcers-23756https://curecurrent.com/trials/soluble-beta-glucan-sbg-as-treatment-for-diabetic-foot-ulcers-23757https://curecurrent.com/trials/insulin-free-cow-milk-formula-in-prevention-of-type-1-diabetes-associated-autoimmunity-findia-pilot-study-23758https://curecurrent.com/trials/effect-of-increased-intake-of-low-fat-dairy-products-on-weight-loss-and-insulin-resistance-23759https://curecurrent.com/trials/effects-of-insulin-detemir-and-nph-insulin-on-renal-handling-of-sodium-fluid-retention-and-weight-in-type-2-diabetic-pat-23760https://curecurrent.com/trials/curcumin-for-type-2-diabetic-patients-23761https://curecurrent.com/trials/changes-of-biomarkers-in-response-to-training-and-antioxidant-treatment-23762https://curecurrent.com/trials/the-effect-of-a-traditional-dietary-intervention-on-diabetes-mellitus-and-cardiovascular-disease-risk-factors-in-a-first-23763https://curecurrent.com/trials/olmesartan-medoxomil-in-diabetes-mellitus-23764https://curecurrent.com/trials/curcumin-therapy-in-patients-with-impaired-glucose-tolerance-and-insulin-resistance-23765https://curecurrent.com/trials/local-application-of-autologous-bone-marrow-cells-for-treatment-of-chronic-diabetic-ulcers-23766https://curecurrent.com/trials/effects-of-lifestyle-modification-on-metabolic-parameters-in-type-2-diabetic-patients-23767https://curecurrent.com/trials/eat-well-live-well-nutrition-program-23768https://curecurrent.com/trials/gait-and-balance-of-diabetes-type-2-patients-23769https://curecurrent.com/trials/incretin-effect-in-lean-and-obese-subjects-23770https://curecurrent.com/trials/the-effects-of-high-and-low-gi-breakfasts-on-cognitive-performance-in-adults-with-type-2-diabetes-23771https://curecurrent.com/trials/the-incretin-effect-in-patients-with-chronic-pancreatitis-23772https://curecurrent.com/trials/selective-rpe-laser-treatment-srt-for-various-macular-diseases-23773https://curecurrent.com/trials/sitagliptin-versus-sulphonylurea-in-type-2-diabetes-during-ramadan-23774https://curecurrent.com/trials/surgical-treatment-of-type-2-diabetes-mellitus-in-35-body-mass-index-bmi-23775https://curecurrent.com/trials/prospective-controlled-trial-on-surgical-treatment-of-type-2-diabetes-patients-with-bmi-25-30-by-means-of-biliopancreati-23776https://curecurrent.com/trials/trial-of-yellow-577-nm-laser-versus-green-532-nm-laser-for-proliferative-diabetic-retinopathy-23777https://curecurrent.com/trials/effect-of-internet-therapeutic-intervention-on-a1c-levels-in-type-2-diabetes-mellitus-dm-23778https://curecurrent.com/trials/myocardial-perfusion-in-type-2-diabetes-23779https://curecurrent.com/trials/the-supplementary-effects-of-the-extract-of-agaricus-blazei-murril-on-type-ii-diabetes-mellitus-dm-23780https://curecurrent.com/trials/effects-of-health-care-provider-mediated-remote-coaching-system-through-the-pda-type-glucometer-and-the-internet-on-diab-23781https://curecurrent.com/trials/aliskiren-versus-ramipril-on-antiproteinuric-effect-in-hypertensive-type-2-diabetic-patients-with-microalbuminuria-23782https://curecurrent.com/trials/study-effects-of-ginkgo-biloba-extract-on-endothelial-cell-function-and-genetic-effects-on-the-response-to-ginkgo-biloba-23783https://curecurrent.com/trials/effect-of-combination-of-mitiglinide-and-metformin-on-glycemic-control-in-patients-with-type-2-diabetes-mellitus-23784https://curecurrent.com/trials/can-insulin-glargine-improve-myocardial-function-in-patients-with-t2d-and-coronary-artery-disease-cad-23785https://curecurrent.com/trials/efficacy-study-of-nabilone-in-the-treatment-of-diabetic-peripheral-neuropathic-pain-23786https://curecurrent.com/trials/protein-hydrolyzation-and-glycemic-control-23787https://curecurrent.com/trials/evaluate-the-glycemic-control-of-ckd-501-in-type-2-diabetes-mellitus-23788https://curecurrent.com/trials/topical-autologous-insulin-application-for-the-treatment-of-corneal-epithelium-defect-after-ocular-surgeries-23789https://curecurrent.com/trials/contraction-exercise-mediated-glucose-uptake-as-a-therapeutic-target-in-type-2-diabetes-23790https://curecurrent.com/trials/comparison-of-two-approaches-to-insulin-therapy-in-patients-with-type-2-diabetes-ioox-23791https://curecurrent.com/trials/effects-of-curcumin-on-postprandial-blood-glucose-and-insulin-in-healthy-subjects-23792https://curecurrent.com/trials/the-effects-of-cinnamon-on-postprandial-blood-glucose-and-insulin-in-subjects-with-impaired-glucose-tolerance-23793https://curecurrent.com/trials/opal-insulin-glulisine-diabetes-mellitus-23794https://curecurrent.com/trials/insulin-glulisine-in-type-1-diabetes-mellitus-23795https://curecurrent.com/trials/eleonor-study-insulin-glulisine-in-type-2-diabetes-mellitus-23796https://curecurrent.com/trials/efficacy-study-on-the-control-of-blood-glucose-concentration-in-type-1-diabetic-patients-23797https://curecurrent.com/trials/lantus-effect-on-myocardial-glucose-metabolism-in-t2-23798https://curecurrent.com/trials/evaluate-quality-of-life-in-type-2-diabetes-before-and-after-change-to-insuline-glargine-23799https://curecurrent.com/trials/insulin-glulisine-in-healthy-lean-and-obese-subjects-23800https://curecurrent.com/trials/lantustitr-insulin-glargine-in-type-2-diabetes-mellitus-23801https://curecurrent.com/trials/sam-skip-a-meal-insulin-glargine-diabetes-mellitus-type-1-23802https://curecurrent.com/trials/insulin-glargine-in-type-2-diabetes-mellitus-23803https://curecurrent.com/trials/to-compare-visual-field-impairment-in-conventional-double-frequency-nd-yag-panretinal-photocoagulation-with-pascal-panre-23804https://curecurrent.com/trials/the-association-between-high-risk-pregnancy-and-sleep-disordered-breathing-23805https://curecurrent.com/trials/vitamin-d-c-reactive-protein-and-insulin-resistance-23806https://curecurrent.com/trials/real-time-continuous-glucose-monitoring-in-pre-school-children-with-type-1-diabetes-mellitus-23807https://curecurrent.com/trials/effects-of-epa-and-vitamin-e-on-leptin-adiponectin-and-enzymatic-antioxidants-in-type-2-dm-23808https://curecurrent.com/trials/effect-of-turmeric-on-diabetic-nephropathy-23809https://curecurrent.com/trials/effects-of-pregabalin-duloxetine-amitriptyline-on-pain-sleep-23810https://curecurrent.com/trials/benfotiamine-in-diabetic-nephropathy-23811https://curecurrent.com/trials/the-dream-diabetes-reduction-assessment-with-ramipril-and-rosiglitazone-medication-trial-23812https://curecurrent.com/trials/electronic-feedback-on-diabetic-care-to-general-practitioners-23813https://curecurrent.com/trials/cholesterol-metabolism-and-lipid-transfer-in-diabetes-23814https://curecurrent.com/trials/effect-of-ezetimibe-on-oxidized-low-density-lipoprotein-ldl-cholesterol-23815https://curecurrent.com/trials/ezetimibe-and-statins-on-postprandial-lipemia-in-type-2-diabetes-23816https://curecurrent.com/trials/effect-of-patient-education-related-to-cv-risk-factors-in-type-2-diabetes-mellitus-patrol-23817https://curecurrent.com/trials/to-study-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd1656-in-japanese-type-2-diabetes-mellitus-t2dm-23818https://curecurrent.com/trials/diabetes-intervention-trial-with-vitamin-d-in-subjects-of-nordic-and-sub-indian-ethnicity-23819https://curecurrent.com/trials/influence-of-binge-drinking-on-glucose-metabolism-in-patients-with-type-1-diabetes-a-pilot-study-23820https://curecurrent.com/trials/effects-of-low-versus-high-carbohydrate-diet-during-rehabilitation-on-cardiovascular-function-and-metabolism-in-type-2-d-23821https://curecurrent.com/trials/the-efficacy-and-safety-study-of-sulodexide-in-filipino-diabetic-patients-with-chronic-kidney-disease-23822https://curecurrent.com/trials/removable-walker-for-neuropathic-ulcers-23823https://curecurrent.com/trials/european-study-of-cardiovascular-risk-23824https://curecurrent.com/trials/effect-of-dipeptidyl-peptidase-iv-inhibitor-and-sulfonylurea-on-glucose-variability-and-oxidative-stress-23825https://curecurrent.com/trials/wound-healing-in-diabetes-why-study-23826https://curecurrent.com/trials/a-comparison-of-insoles-used-to-prevent-neuropathic-diabetic-foot-ulceration-23827https://curecurrent.com/trials/quantification-of-the-incretin-effect-in-healthy-subjects-and-patients-with-type-2-diabetes-23828https://curecurrent.com/trials/a-safety-and-efficacy-study-of-vitreosolve-for-non-proliferative-diabetic-retinopathy-subjects-23829https://curecurrent.com/trials/glulisine-lantus-in-type-i-patients-23830https://curecurrent.com/trials/long-term-safety-study-of-inhaled-insulin-cp-464-005-inhaler-in-japanese-patients-with-type1-or-type2-diabetes-23831https://curecurrent.com/trials/comparison-between-technosphere-insulin-inhalation-powder-versus-rapid-acting-insulin-in-subjects-with-type-2-diabetes-m-23832https://curecurrent.com/trials/to-compare-the-effect-of-inhaled-insulin-with-subcutaneously-injected-insulin-in-subjects-with-type-2-diabetes-mellitus-23833https://curecurrent.com/trials/a-3-month-randomized-open-label-multi-center-study-of-technosphere-insulin-compared-to-insulin-aspart-in-subjects-with-t-23834https://curecurrent.com/trials/intravitreal-ranibizumab-for-persistent-new-vessels-in-diabetic-retinopathy-inipe-study-23835https://curecurrent.com/trials/intravitreal-injection-versus-sub-tenon-s-infusion-of-triamcinolone-acetonide-for-refractory-diabetic-macular-edema-duri-23836https://curecurrent.com/trials/diabetes-prevention-in-estrie-23837https://curecurrent.com/trials/comparison-of-the-efficacy-and-safety-between-pioglitazone-and-placebo-added-to-combination-therapy-in-type-2-diabetes-23838https://curecurrent.com/trials/determining-rates-of-cardiovascular-complications-among-patients-of-a-managed-diabetes-care-program-23839https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-jnj-38431055-in-healthy-male-volunt-23840https://curecurrent.com/trials/types-of-starch-and-their-effect-on-blood-glucose-appetite-and-food-intake-23841https://curecurrent.com/trials/the-effect-of-whey-protein-on-short-term-food-intake-and-post-meal-blood-glucose-response-in-young-men-23842https://curecurrent.com/trials/islet-transplantation-using-campath-1h-and-infliximab-induction-23843https://curecurrent.com/trials/phase-ii-study-of-heart-polypill-safety-and-efficacy-in-primary-prevention-of-cardiovascular-disease-23844https://curecurrent.com/trials/the-effect-of-whey-protein-and-its-hydrolysate-on-pre-and-post-fixed-meal-glycemia-and-insulin-in-young-adults-23845https://curecurrent.com/trials/6-month-safety-and-efficacy-study-of-ttp488-in-patients-with-type-2-diabetes-and-persistent-albuminuria-23846https://curecurrent.com/trials/phase-i-study-in-healthy-volunteers-to-assess-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-azd4017-a-23847https://curecurrent.com/trials/insulin-glargine-combination-therapies-in-type-ii-diabetics-23848https://curecurrent.com/trials/gulf-lantus-apidra-evaluation-in-type-1-diabetics-study-23849https://curecurrent.com/trials/hyperglycemia-in-a-coronary-intensive-care-unit-23850https://curecurrent.com/trials/retinal-function-in-relation-to-long-term-changes-in-the-glucose-level-23851https://curecurrent.com/trials/a-clinical-study-of-grc-8200-in-type-2-diabetes-mellitus-23852https://curecurrent.com/trials/the-retinal-function-in-relation-to-glucose-changes-23853https://curecurrent.com/trials/predictive-and-protective-factors-in-the-cause-of-diabetes-a-study-in-twins-23854https://curecurrent.com/trials/effect-of-januvia-on-beta-cell-function-in-patients-with-diabetes-mellitus-23855https://curecurrent.com/trials/oral-insulin-a-comparison-with-subcutaneous-regular-human-insulin-in-patients-with-type-2-diabetes-23856https://curecurrent.com/trials/improving-diabetic-foot-ulcers-with-atorvastatin-23857https://curecurrent.com/trials/anti-inflammatory-actions-of-valsartan-in-patients-with-type-2-diabetes-mellitus-23858https://curecurrent.com/trials/types-of-starch-and-their-effect-on-blood-glucose-appetite-and-food-intake-23859https://curecurrent.com/trials/green-tea-high-in-epigallocatechin-gallate-egcg-and-postprandial-fat-oxidation-23860https://curecurrent.com/trials/insulin-glulisine-diabetes-mellitus-type-1-23861https://curecurrent.com/trials/closing-the-loop-in-adults-with-type-1-diabetes-23862https://curecurrent.com/trials/how-does-the-diabetes-drug-pioglitazone-reduce-protein-loss-in-the-urine-23863https://curecurrent.com/trials/lantus-versus-levemir-treat-to-target-23864https://curecurrent.com/trials/opposing-step-by-step-insulin-reinforcement-to-intensified-strategy-23865https://curecurrent.com/trials/is-carotid-intima-media-thickness-affected-by-a1c-variability-23866https://curecurrent.com/trials/insulin-glargine-in-type-2-diabetes-mellitus-23867https://curecurrent.com/trials/clinical-test-of-blood-glucose-test-strips-23868https://curecurrent.com/trials/insulin-glulisine-in-diabetes-mellitus-type-2-23869https://curecurrent.com/trials/insulin-glargine-in-type-2-diabetic-patients-23870https://curecurrent.com/trials/insulin-glulisine-insulin-lispro-and-insulin-glargine-in-type-1-or-2-diabetes-mellitus-23871https://curecurrent.com/trials/irbesartan-in-chinese-hypertensive-diabetics-with-microalbuminuria-23872https://curecurrent.com/trials/gastric-modulator-tantalus-system-versus-insulin-treatment-in-obese-type-2-diabetic-patients-a-randomized-control-trial-23873https://curecurrent.com/trials/impact-of-functional-insulinotherapy-on-blood-glucose-variability-indicators-in-patients-with-type-1-diabetes-23874https://curecurrent.com/trials/interaction-study-slv337-simvastatin-23875https://curecurrent.com/trials/adjunctive-therapy-of-exenatide-or-sitagliptin-to-insulin-glargine-in-type-2-diabetes-23876https://curecurrent.com/trials/expanded-pk-and-pd-of-insulin-glulisine-versus-insulin-aspart-in-healthy-volunteers-23877https://curecurrent.com/trials/ketoacidosis-in-individuals-with-type-i-diabetes-mellitus-t1dm-23878https://curecurrent.com/trials/home-monitoring-in-the-management-of-hypertension-and-diabetes-mellitus-23879https://curecurrent.com/trials/intravenous-insulin-in-patients-with-diabetes-after-percutaneous-coronary-intervention-pci-23880https://curecurrent.com/trials/placebo-controlled-dose-escalation-study-in-subjects-with-type-2-diabetes-mellitus-being-treated-with-sulfonylurea-23881https://curecurrent.com/trials/combination-of-glinides-with-premixed-insulin-23882https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glulisine-in-type-1-diabetes-mellitus-23883https://curecurrent.com/trials/efficacy-and-safety-of-insulin-glulisine-in-type-2-diabetes-mellitus-23884https://curecurrent.com/trials/comparison-of-the-effects-of-repaglinide-and-metformin-on-glucose-excursions-23885https://curecurrent.com/trials/a-study-to-characterize-the-pharmacokinetics-pharmacodynamics-and-effect-of-food-of-da-1229-in-healthy-male-subjects-23886https://curecurrent.com/trials/immunointervention-with-calcitriol-in-new-onset-type-1-diabetes-23887https://curecurrent.com/trials/far-infrared-radiation-treatment-for-diabetes-23888https://curecurrent.com/trials/effect-of-inhaled-steroids-on-glucose-regulation-in-asthma-patients-23889https://curecurrent.com/trials/the-effects-of-omega-3-fatty-acid-omacor-on-the-low-density-lipoprotein-ldl-sub-fraction-in-type-2-diabetic-patients-23890https://curecurrent.com/trials/niddm-and-ir-in-combination-therapy-for-chc-23891https://curecurrent.com/trials/incretin-physiology-associated-with-steroid-hormone-treatment-23892https://curecurrent.com/trials/a-randomized-controlled-trial-of-a-novel-community-based-primary-and-secondary-cardiovascular-prevention-program-23893https://curecurrent.com/trials/nutrition-diabetes-and-pulmonary-tb-hiv-23894https://curecurrent.com/trials/effect-of-exenatide-on-glucose-homeostasis-determinants-in-type-2-diabetes-23895https://curecurrent.com/trials/prevention-of-contrast-induced-nephropathy-in-diabetic-patients-with-undergoing-coronary-angiography-23896https://curecurrent.com/trials/safety-of-add-on-aliskiren-to-angiotensin-converting-enzyme-inhibitor-acei-and-angiotensin-i-receptor-blocker-arb-treatm-23897https://curecurrent.com/trials/type-2-diabetes-and-exercise-a-pilot-study-23898https://curecurrent.com/trials/risk-factors-of-incidence-of-type-2-diabetes-and-cardiovascular-diseases-shanghai-baoshan-study-23899https://curecurrent.com/trials/carotid-intima-media-thickness-imt-and-large-vessel-atherosclerosis-by-multidetector-computed-tomography-mdct-23900https://curecurrent.com/trials/insulin-dose-titration-system-using-a-short-messaging-service-sms-automatically-produced-by-a-knowledge-matrix-23901https://curecurrent.com/trials/cholesterol-and-fatty-acid-synthesis-in-islet-and-liver-transplant-patients-and-effect-of-dietary-intervention-23902https://curecurrent.com/trials/glycemic-optimization-treatment-study-23903https://curecurrent.com/trials/effect-of-dmmet-01-on-insulin-sensitivity-in-naive-type-2-diabetes-patients-clamp-23904https://curecurrent.com/trials/to-investigate-the-effect-of-rosiglitazone-and-ramipril-on-pre-clinical-vasculopathy-in-diabetes-and-igt-patients-23905https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-mersina-an-ayurvedic-formulation-a-double-blind-placebo-controlled-study-in-type-2-23906https://curecurrent.com/trials/efficacy-of-exercise-at-a-fitness-club-for-cardiovascular-risk-reduction-23907https://curecurrent.com/trials/vitamin-d-and-type-2-diabetes-a-cross-sectional-study-23908https://curecurrent.com/trials/survey-on-the-treatment-of-hypertension-in-patients-with-type-2-diabetes-23909https://curecurrent.com/trials/assess-pharmacokinetics-safety-and-tolerability-in-healthy-chinese-volunteers-after-oral-doses-of-saxagliptin-23910https://curecurrent.com/trials/changes-of-the-infusion-rate-in-insulin-pump-treatment-23911https://curecurrent.com/trials/follow-up-glucose-levels-among-infants-of-diabetic-mothers-23912https://curecurrent.com/trials/glucagon-modulation-of-ghrelin-secretion-23913https://curecurrent.com/trials/acarbose-and-secondary-prevention-after-coronary-stenting-23914https://curecurrent.com/trials/the-effect-of-amlodipine-and-lisinopril-on-retinal-autoregulation-in-type-1-diabetes-23915https://curecurrent.com/trials/type-2-diabetes-and-acute-myocardial-infarction-23916https://curecurrent.com/trials/environmental-exposure-to-lead-and-progressive-renal-insufficiency-in-type-ii-diabetic-nephropathy-23917https://curecurrent.com/trials/the-evaluation-of-safety-and-efficacy-of-jwhgwt-on-diabetic-neuropathy-23918https://curecurrent.com/trials/the-effects-of-renin-angiotensin-system-blockage-ras-calcium-channel-blocker-and-combined-drugs-on-tweak-ptx3-and-fmd-le-23919https://curecurrent.com/trials/a-clinical-trial-on-diabetic-foot-using-peripheral-blood-derived-stem-cells-for-treating-critical-limb-ischemia-23920https://curecurrent.com/trials/a-study-for-patients-with-diabetes-mellitus-iopa-23921https://curecurrent.com/trials/lapas-study-insulin-glargine-in-type-2-diabetes-mellitus-23922https://curecurrent.com/trials/glulisine-lantus-in-type-i-patients-23923https://curecurrent.com/trials/evaluation-rehabilitation-on-glycometabolic-state-in-non-diabetic-coronary-artery-disease-cad-patients-23924https://curecurrent.com/trials/prevention-of-type-2-diabetes-mellitus-by-l-arginine-in-patients-with-metabolic-syndrome-23925https://curecurrent.com/trials/use-of-mellitor-sensor-for-continuous-glucose-monitoring-an-ex-vivo-study-23926https://curecurrent.com/trials/effect-of-renin-angiotensin-system-blockade-on-the-fas-antigen-cd95-and-asymmetric-dimethylarginine-adma-levels-in-type-23927https://curecurrent.com/trials/insulin-resistance-and-end-stage-renal-disease-the-role-of-retinol-binding-protein-4-23928https://curecurrent.com/trials/glucagon-in-the-treatment-of-hypoglycemia-in-newborn-infants-of-diabetic-mothers-23929https://curecurrent.com/trials/a-proof-of-concept-study-of-darbepoetin-alfa-in-partial-correction-of-anemia-in-chinese-with-diabetic-nephropathy-23930https://curecurrent.com/trials/the-use-of-cilostazol-in-patients-with-diabetic-nephropathy-23931https://curecurrent.com/trials/visual-function-center-point-thickness-and-macular-volume-after-photocoagulation-23932https://curecurrent.com/trials/the-effectiveness-of-diabetes-patient-education-and-self-management-education-in-persons-with-type-2-diabetes-23933https://curecurrent.com/trials/diabetes-and-metabolic-postprandial-responses-23934https://curecurrent.com/trials/avandamet-versus-metformin-and-sulphonylurea-in-people-with-poorly-controlled-type-2-diabetes-23935https://curecurrent.com/trials/study-of-crx-401-on-glucose-levels-in-subjects-with-type-ii-diabetes-23936https://curecurrent.com/trials/effects-of-different-doses-of-aspirin-on-pathophysiological-markers-in-type-2-diabetes-23937https://curecurrent.com/trials/can-enhanced-glycemic-control-in-type-ii-diabetics-improve-myocardial-protection-during-coronary-artery-bypass-grafting-23938https://curecurrent.com/trials/a-clinical-trial-comparing-the-efficacy-and-safety-of-2-different-initial-dose-prescriptions-for-exubera-23939https://curecurrent.com/trials/randomized-controlled-trial-of-home-telemonitoring-for-elderly-people-23940https://curecurrent.com/trials/comparison-of-vehicle-delivery-depth-using-the-novofine-5-mm-needle-with-or-without-a-skin-fold-and-inserted-at-either-4-23941https://curecurrent.com/trials/omacor-for-the-treatment-of-vascular-dysfunction-in-patients-with-type-2-diabetes-mellitus-23942https://curecurrent.com/trials/24-hour-glycemia-rosiglitazone-versus-glimepiride-in-type-2-diabetes-23943https://curecurrent.com/trials/relationship-between-body-weight-and-glycohemoglobin-23944https://curecurrent.com/trials/a-study-of-the-efficacy-of-prolonged-release-melatonin-versus-placebo-in-diabetic-patients-suffering-from-insomnia-23945https://curecurrent.com/trials/gallant-14-tesaglitazar-vs-metformin-and-fenofibrate-23946https://curecurrent.com/trials/efficacy-of-music-on-reduction-of-sedative-drugs-in-mechanically-ventilated-intensive-care-unit-patients-23947https://curecurrent.com/trials/gallant-2-tesaglitazar-vs-placebo-23948https://curecurrent.com/trials/dose-response-study-in-japanese-patients-23949https://curecurrent.com/trials/diabetic-macular-edema-severity-at-diagnosis-23950https://curecurrent.com/trials/gallant-8-tesaglitazar-add-on-to-metformin-23951https://curecurrent.com/trials/does-a-low-fat-vegetarian-diet-improve-insulin-resistance-in-individuals-with-type-2-diabetes-23952https://curecurrent.com/trials/genetic-physiopathology-and-evolution-of-type-2-diabetes-23953https://curecurrent.com/trials/glycemic-responses-and-sensory-characteristics-of-whole-yellow-pea-flour-added-to-novel-functional-foods-23954https://curecurrent.com/trials/amylin-and-glucagon-like-peptide-1-glp-1-influence-on-gastric-emptying-appetite-and-food-intake-in-humans-23955https://curecurrent.com/trials/influence-of-glucagon-inhibition-in-relation-to-the-anti-diabetic-effect-of-glucagon-like-peptide-1-glp-1-in-patients-wi-23956https://curecurrent.com/trials/role-of-pioglitazone-in-preventing-diabetes-23957https://curecurrent.com/trials/the-effect-of-pramlintide-on-meal-time-insulin-bolus-23958https://curecurrent.com/trials/tight-intra-operative-glucose-control-during-coronary-artery-bypass-surgery-23959https://curecurrent.com/trials/a-study-to-evaluate-nbi-6024-in-adult-and-adolescent-patients-with-new-onset-of-type-1-diabetes-mellitus-23960https://curecurrent.com/trials/banded-sleeve-gastrectomy-versus-banded-ring-gastric-bypass-in-morbidly-obese-patients-23961https://curecurrent.com/trials/aldosterone-in-diabetic-nephropathy-23962https://curecurrent.com/trials/autonomic-nervous-activity-in-women-with-gestational-diabetes-23963https://curecurrent.com/trials/oral-acetazolamide-brimonidine-tartarate-and-anterior-chamber-paracentesis-for-ocular-hypertension-control-after-intravi-23964https://curecurrent.com/trials/early-detection-of-arteriosclerosis-23965https://curecurrent.com/trials/glucagon-like-peptide-1-glp-1-suppression-of-alpha-cell-secretion-in-type-2-diabetes-mellitus-t2dm-23966https://curecurrent.com/trials/needle-length-in-obese-insulin-using-diabetic-subjects-23967https://curecurrent.com/trials/apidra-registration-study-23968https://curecurrent.com/trials/assessment-of-the-efficacy-of-rosuvastatin-in-patient-groups-with-a-dissimilar-risk-profile-in-an-observational-study-he-23969https://curecurrent.com/trials/medical-nutrition-therapy-program-for-pregnant-women-with-diabetes-23970https://curecurrent.com/trials/efficacy-of-glp-1-infusion-in-comparison-to-an-insulin-infusion-protocol-to-reach-normoglycemia-type-2-diabetic-patients-23971https://curecurrent.com/trials/the-effects-of-soy-protein-and-isoflavones-on-glycemic-control-insulin-sensitivity-and-cardiovascular-risk-factors-23972https://curecurrent.com/trials/effects-of-high-voltage-pulsed-current-hvpc-and-low-level-laser-therapy-lllt-on-wound-healing-in-diabetic-ulcers-23973https://curecurrent.com/trials/nerve-morphology-in-diabetic-patients-23974https://curecurrent.com/trials/hyperglycemia-in-the-intensive-care-unit-a-prevalence-study-23975https://curecurrent.com/trials/exercise-effects-on-cardiovascular-risk-factors-quality-of-life-muscle-function-in-type-2-diabetes-and-healthy-persons-23976https://curecurrent.com/trials/placebo-controlled-dose-response-study-of-rivoglitazone-in-type-2-diabetes-23977https://curecurrent.com/trials/the-effect-of-intravitral-injection-of-triamcinolone-combined-with-cataract-surgery-phacoemulsification-on-diabetic-macu-23978https://curecurrent.com/trials/treatment-of-refractory-diabetic-macular-edema-with-infliximab-23979https://curecurrent.com/trials/shiga-progression-of-diabetes-nephropathy-and-retinopathy-23980https://curecurrent.com/trials/the-meal-tray-as-a-tool-and-platform-to-change-eating-habits-among-hospitalized-diabetic-patients-an-intervention-study-23981https://curecurrent.com/trials/drug-drug-interaction-study-of-mitiglinide-and-gemfibrozil-23982https://curecurrent.com/trials/the-reduction-in-glucose-stimulated-insulin-secretion-induced-by-cytokines-may-be-prevented-by-copper-addition-studies-i-23983https://curecurrent.com/trials/coronary-flow-reserve-and-glucometabolic-state-23984https://curecurrent.com/trials/insulin-resistance-and-hypertensive-disorders-in-pregnancy-23985https://curecurrent.com/trials/prospective-influence-of-bedtime-insulin-glargine-on-mobilization-and-function-of-endothelial-progenitor-cells-23986https://curecurrent.com/trials/the-effects-of-gip-and-glp-2-on-the-secretion-of-glucagon-in-patients-with-type-1-diabetes-23987https://curecurrent.com/trials/a-crossover-study-with-hexalacton-in-patients-with-type-1-diabetes-and-microalbuminuria-23988https://curecurrent.com/trials/green-laser-photocoagulation-study-in-proliferative-diabetic-retinopathy-23989https://curecurrent.com/trials/safety-study-to-evaluate-bms-767778-in-healthy-subjects-and-subjects-with-type-2-diabetes-mellitus-t2dm-23990https://curecurrent.com/trials/trial-of-herb-yuyang-ointment-to-diabetic-foot-ulcer-23991https://curecurrent.com/trials/dose-ranging-study-evaluating-ave2268-in-patients-with-type-2-diabetes-not-adequately-controlled-by-a-metformin-treatmen-23992https://curecurrent.com/trials/placebo-and-active-comparator-controlled-dose-response-study-of-rivoglitazone-in-type-2-diabetes-23993https://curecurrent.com/trials/pharmacokinetics-of-iasp-following-csii-in-patients-with-t1dm-23994https://curecurrent.com/trials/bst-dermon-versus-standard-of-care-in-the-treatment-of-diabetic-foot-ulcers-23995https://curecurrent.com/trials/randomised-trial-of-health-coaching-in-secondary-prevention-of-diabetes-and-heart-disease-23996https://curecurrent.com/trials/study-on-tear-proteins-in-diabetic-retinopathy-of-type-2-diabetics-23997https://curecurrent.com/trials/study-of-alagebrium-in-patients-with-insulin-dependent-type-1-diabetes-and-microalbuminuria-23998https://curecurrent.com/trials/comparison-of-eprosartan-hct-versus-enalapril-hct-in-hypertensives-with-type-ii-diabetes-23999https://curecurrent.com/trials/incretin-hormones-in-type-1-diabetes-mellitus-glycemic-response-in-type-1-diabetes-mellitus-24000